Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Hope S. Rugo
Based on 155 articles published since 2010
(Why 155 articles?)
||||
Expertise Level
The expertise of Hope S. Rugo ranks in the
  • Top 0.00037%
  • ... of 273,648 published authors worldwide on Breast Neoplasms
  • ... from 2010 through 2020
  • ... based on contributions to 155 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Rugo, H S   ·   Rugo, H   ·   Rugo, Hope S   ·   Rugo, Hope
Work Locations
Details
Most likely:    University of California San Francisco   Contact    
2019
  • From the University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco. · Pubmed 31340099
  • Department of Medicine (Hematology/Oncology), University of California San Francisco Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St., Box 1710, San Francisco, CA, 94143-1710, USA. · Division of Gastroenterology, University of South Alabama College of Medicine, 75 S. University Blvd., Mobile, AL, 36688, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe, Unit 1354, Houston, TX, 77030, USA. · Puma Biotechnology, Inc., 10880 Wilshire Blvd. Suite 2150, Los Angeles, CA, 90024, USA. · Puma Biotechnology, Inc., 701 Gateway Blvd, Suite 500, South San Francisco, CA, 94080, USA. · QED Therapeutics, 421 Kipling St, Palo Alto, CA, 94301, USA. · City of Hope Medical Group, Inc, 1500 E Duarte Rd, Duarte, CA, 91010, USA. · Pubmed 30671765
  • From Institut Gustave Roussy, INSERM Unité 981, Université Paris-Sud, Villejuif (F.A.), Institut de Cancérologie de l'Ouest, St. Herblain (M.C.), and Novartis Pharma, Paris (A.-S.L.) - all in France · Hospital Universitario 12 de Octubre, Madrid (E.C.) · National Institute of Oncology (G.R.) and Duna Medical Center (Z.P.), Budapest, Hungary · German Breast Group, Neu-Isenburg, and Center for Hematology and Oncology Bethanien, Frankfurt - both in Germany (S.L.) · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco (H.S.R.) · Aichi Cancer Center, Nagoya (H.I.), Kanagawa Cancer Center, Yokohama (T.Y.), Saitama Cancer Center, Saitama (K.I.), and National Hospital Organization Hokkaido Cancer Center, Sapporo (M.T.) - all in Japan · Istituto Oncologico Veneto and the Departments of Surgery, Oncology, and Gastroenterology, University of Padua, Padua, Italy (P.C.) · Vanderbilt University, Nashville (I.A.M.) · Chaim Sheba Medical Center, Tel Hashomer, Israel (B.K.) · National Taiwan University Hospital, Taipei (Y.-S.L.) · Novartis Pharma, Basel, Switzerland (D.M., C.W.) · Novartis Pharmaceuticals, East Hanover, NJ (S.H.) · and Massachusetts General Hospital Cancer Center, Boston (D.J.). · Pubmed 31091374
  • The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX 77030, USA. · Dana-Farber Cancer Institute, Center for Women's Cancers, Boston, MA 02215, USA. · Memorial Sloan-Kettering Cancer Center, Bobst International Center, New York, NY 10065, USA. · University of North Carolina School of Medicine, Duke Cancer Center, Chapel Hill, NC 27710, USA. · University of California San Francisco, Department of Medicine (Hematology/Oncology), San Francisco, CA 94115, USA. · University of Leeds, Leeds Institute of Cancer and Pathology (LICAP), Leeds, LS2 9JT, UK. · St James' University Hospital, Institute of Oncology, Leeds, LS9 7BE, UK. · Institut Curie, Oncological Medicine Department, 75248, Paris, France. · University Medical Center Hamburg-Eppendorf, Department of Obstetrics and Gynecology, 20246 Hamburg, Germany. · Nektar Therapeutics, San Francisco, CA 94158, USA. · IOB Institute of Oncology, Quironsalud Group, 28034 Madrid & 08023 Barcelona, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Breast Cancer and Melanoma Group, 08035 Barcelona, Spain. · Pubmed 31074641
  • Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, 450 Brookline Avenue, Boston, MA, USA. · Department of Statistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Breast Cancer Medicine Service, Solid Tumor Division, Department of Medicine, Memorial Sloan Kettering Cancer Center and Department of Medicine, Weill Cornell Medical Center, New York, NY, USA. · Department of Medical Oncology, Sarah Cannon Cancer Center, Nashville, TN, USA. · Department of Hematology-Oncology, Massachusetts General Hospital, Boston, MA, USA. · Division of Medical Oncology, Department of Medicine, Duke Cancer Institute, Durham, NC, USA. · Division of Hematology/Oncology, Department of Medicine, Cardinal Bernardin Cancer Center, Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA. · Department of Medicine, Division of Oncology, Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Department of Medical Oncology, Baylor Clinic-Lester and Sue Smith Breast Center, Houston, TX, USA. · Department of Oncology, Johns Hopkins Kimmel Cancer Center, Baltimore, MD, USA. · Department of Medical Oncology, UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · American Society of Clinical Oncology, Alexandria, VA, USA. · Pubmed 31004299
  • From the Massachusetts General Hospital Cancer Center (A.B., S.J.I.) and Dana-Farber Cancer Institute (S.M.T.), Harvard Medical School, Boston · Vanderbilt-Ingram Cancer Center, Nashville (I.A.M., V.G.A.) · Weill Cornell Medical College (L.T.V.) and New York-Presbyterian-Columbia University Irving Medical Center (K.K.), New York · University of Colorado Cancer Center, Aurora (J.R.D.) · Texas Oncology, Baylor University Medical Center, US Oncology, Dallas (J.O.) · Orlando Health University of Florida Health Cancer Center, Orlando (R.L.M., N.C.S.) · Yale University School of Medicine, New Haven, CT (A.D.S.) · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco (H.S.R.) · Immunomedics, Morris Plains, NJ (D.M.G., R.I., S.W., R.M.S., W.A.W.) · and AIS Consulting, Ann Arbor, MI (A.M.S.). · Pubmed 30786188
  • Department of Medicine (Hematology/Oncology), University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St, 2nd Floor, San Francisco, CA, 94115, USA. · Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Santa Monica, CA, USA. · Department of Medical Oncology, Institut Curie, Paris, France. · Centre Eugène Marquis, Rennes, France. · Frauenklinik und Poliklinik Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Republican Clinical Oncology Dispensary, State Budget Medical Institution, Ufa, Russia. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada. · Department of Obstetrics and Gynecology, Brustzentrum der Universität München (LMU), Munich, Germany. · Breast Cancer Center, Memorial Cancer Institute, Hollywood, FL, USA. · Patient and Health Impact, Pfizer Inc, New York, NY, USA. · Clinical Statistics, Pfizer Inc, La Jolla, CA, USA. · Global Product Development, Clinical, Pfizer S.r.l, Milan, Italy. · Global Product Development, Clinical, Pfizer Inc, San Francisco, CA, USA. · Global Product Development, Clinical, Pfizer Inc, Collegeville, PA, USA. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada. · Pubmed 30632023
  • Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston. · Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston. · at the time of the study, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Oncology, Sarah Cannon Research Institute, Tennessee Oncology Professional Limited Liability Corporation, Nashville. · Department of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, German Cancer Consortium, Germany. · Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany. · Department of Hematology/Oncology, SozialStiftung Bamberg, Bamberg, Germany. · Department of Medical Oncology, Catalan Institute of Oncology-Bellvitge Biomedical Research Institute, Barcelona, Spain. · Department of Oncology, Churchill Hospital Cancer Centre, Oxford, United Kingdom. · At the time of the study, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Cellex Center, Barcelona, Spain. · Translational Clinical Oncology, Novartis Pharma AG, Basel, Switzerland. · At the time of the study, Novartis Oncology Translational Research, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts. · Tango Therapeutics, Cambridge, Massachusetts. · Department of Medicine, University of California at San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco. · Pubmed 30543347
  • Department of Biostatistics and Epidemiology, University of California San Francisco, San Francisco, California, USA. · Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA. · Alliance Statistics and Data Center, Duke University, Durham, North Carolina, USA. · Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan. · Department of Medicine, Northwestern University, Chicago, Illinois, USA. · Department of Medicine, University of California San Francisco, San Francisco, California, USA. · DeBartolo Family Personalized Medicine Institute, Moffitt Cancer Center, Tampa, Florida, USA. · Department of Medicine, The University of Chicago, Chicago, Illinois, USA. · Nash General Hospital, Rocky, North Carolina, USA. · Washington University School of Medicine, St. Louis, Missouri, USA. · Dana-Farber/Partners Cancer Care, Boston, Massachusetts, USA. · Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA. · Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA. · Pubmed 30260474
  • Department of Medicine (Hematology/Oncology), University of California San Francisco, Comprehensive Cancer Center, San Francisco, CA. Electronic address: · Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Santa Monica, CA. · Department of Medical Oncology, British Columbia Cancer, Vancouver, BC, Canada. · Division of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada. · Department of OB&GYN, Brustzentrum, Frauenklinik der Universität München (LMU), Munich, Germany. · Memorial Healthcare System, Breast Cancer Center, Pembroke Pines, FL. · Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan. · Department of Medical Oncology, St Vincent's University Hospital and Cancer Trials Ireland, Dublin, Ireland. · Global Product Development, Clinical, Pfizer S.r.l., Milan, Italy. · Global Product Development, Clinical, Pfizer Inc, San Francisco, CA. · Pfizer Inc, Clinical Statistics, La Jolla, CA. · Pfizer Oncology, US Medical Affairs, New York, NY. · Hospital Gregorio Maranon, Universidad Complutense, Madrid, Spain. · Oncologie sénologique, Centre Eugene Marquis, Rennes, France, and Institut Curie, Paris, France. · Pubmed 31836434
  • The University of Chicago, Chicago, Illinois, USA. · Center for Translational Medicine, University of Maryland, Baltimore, Maryland, USA. · Alliance Statistics and Data Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Dana-Farber/Partners CancerCare/Harvard Cancer Center, Boston, Massachusetts, USA. · Heartland Cancer Research NCORP, St. Louis, Missouri, USA. · Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA. · Mayo Clinic, Jacksonville, Florida, USA. · John H. Stroger Jr Hospital of Cook County, Chicago, Illinois, USA. · Decatur Memorial Hospital/Cancer Care Specialists of Illinois/Heartland Cancer Research NCORP, Decatur, Illinois, USA. · University of California San Francisco, San Francisco, California, USA. · Pubmed 31802506
  • University of California, Los Angeles, Los Angeles, California, USA · Institut Paoli-Calmettes, Marseille, France. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Seoul National University Hospital, Seoul, South Korea. · Kaiser Permanente, Northern California, Vallejo, California, USA. · MD Anderson Cancer Center, Gilbert, Arizona, USA. · Rocky Mountain Cancer Centers, Littleton, Colorado, USA. · Baylor Sammons Cancer Center Texas Oncology, U.S. Oncology, Dallas, Texas, USA. · Pfizer Ltd, Surrey, United Kingdom. · Pfizer, Inc., La Jolla, California, USA. · Pfizer Inc., Collegeville, Pennsylvania, USA. · Pfizer Inc., San Francisco, California, USA. · Pfizer Inc., Cambridge, Massachusetts, USA. · The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Obstetrics and Gynecology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Pubmed 31767793
  • Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA. · Philip R. Lee Institute for Health Policy Studies, Center for Healthcare Value, University of California, San Francisco, CA, USA. · Department of Medicine, Epidemiology & Biostatistics, San Francisco, CA, USA. · Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Sutter Medical Foundation, Sacramento, CA, USA. · Pubmed 31736191
  • Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA · Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. · Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA. · Florida Precision Oncology, a division of 21st Century Oncology, Boca Raton, Florida, USA. · Breast Oncology, Division of Hematology/Oncology, University of Vermont Cancer Center, University of Vermont Medical Center, Burlington, Vermont, USA. · Inflammatory Breast Cancer Research Foundation, West Lafayette, Indiana, USA. · Department of Medical Oncology, Baylor University Medical Center, Texas Oncology and U.S. Oncology, Dallas, Texas, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA. · Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C., USA. · Sarah Cannon Research Institute and Tennessee Oncology, Nashville, Tennessee, USA. · Personalized Healthcare, Product Development, Genentech, Inc., South San Francisco, California, USA. · U.S. Medical Affairs, F. Hoffmann-La Roche, Mississauga, Ontario, Canada. · U.S. Medical Affairs, Genentech, Inc., South San Francisco, California, USA. · David Geffen School of Medicine, University of California Los Angeles, Los Angeles California, USA. · Pubmed 31611330
  • Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. Electronic address: · McGill University Health Centre, Montreal, QC, Canada. · German Breast Group, Neu-Isenburg, Germany. · University of Ulm, Ulm, Germany. · Texas Oncology-Baylor Sammons Cancer Center/U.S. Oncology, Dallas, TX, USA. · University of California San Francisco, San Francisco, CA, USA. · NSABP Foundation and Allegheny General Hospital, Pittsburgh, PA, USA. · AbbVie, North Chicago, IL, USA. · Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · Women and Infants Hospital of Rhode Island, Providence, RI, USA. · Helios Klinikum Berlin-Buch, Berlin, Germany. · Pubmed 31606288
  • BC Cancer, Vancouver, BC, Canada. · Feinberg School of Medicine, Robert H. Lurie Cancer Center of Northwestern University, Chicago, IL, USA. · Diller Family Comprehensive Cancer Center, University of California San Francisco Helen, San Francisco, CA, USA. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada. · Breast Cancer Center, Memorial Healthcare System, Hollywood, FL, USA. · Mercy Hospital St. Louis, St. Louis, MO, USA. · Pfizer Oncology, Milan, Italy. · Pfizer Oncology, Cambridge, MA, USA. · Pfizer Inc, La Jolla, CA, USA. · Pfizer Oncology, New York, NY, USA. · David Geffen School of Medicine, University of California Los Angeles, Santa Monica, CA, USA. · Pubmed 31448513
  • Susan F. Smith Center for Women's Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Division of Hematology and Oncology, University of Pennsylvania Abramson Cancer Center, Philadelphia. · Division of Hematology and Medical Oncology, University of California San Francisco Helen Diller Comprehensive Cancer Center, San Francisco. · Division of Hematology/Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis. · Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston. · Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center, Boston. · Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston. · Pfizer, Inc., New York, USA. · Pubmed 31250880
  • Department of Medical Oncology, Centre Eugène Marquis, Rennes, France · Brustzentrum der Universität München, Munich, Germany. · Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. · British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Frauenklinik und Poliklinik Klinikum rechts der Isar, Technische Universität, München, Munich, Germany. · University of Calgary, Calgary, Alberta, Canada. · Pfizer Inc., La Jolla, California, USA. · Pfizer Inc., San Francisco, California, USA. · Pfizer Inc., New York New York, USA. · Pfizer s.r.l., Milan, Italy. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · David Geffen School of Medicine at UCLA, Santa Monica, California, USA. · Pubmed 31217344
  • Department of Medicine, Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA, USA. · Wellstar Atlanta Medical Center, Atlanta, GA, USA. · Emeritus Professor, Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA. · Department of Medicine, Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA, USA. · Pubmed 31172405
  • Department of Medicine, Perlmutter Cancer Center, New York University School of Medicine, New York, USA. · Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University London, London, UK. · Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco. · Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Institut Curie, Paris, France. · Oncology Medicine Department, Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Aichi Cancer Center Hospital, Nagoya, Japan. · Institut de Cancerologie de l'Ouest, Nantes, France. · Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, USA. · Westmead Hospital and the University of Sydney, Sydney, Australia. · Department of Oncology and Hematology, University of Milano, Milan. · IEO, European Institute of Oncology IRCCS, Milano, Milan, Italy. · Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, USA. · Baylor University Medical Center, Dallas. · Texas Oncology, Dallas. · US Oncology, Dallas, USA. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · Breast Cancer Service for Young Women, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel. · Levine Cancer Institute, Atrium Health, Charlotte. · Merck & Co., Inc., Kenilworth, USA. · Breast Cancer Program, Vall d'Hebron Institute of Oncology, Barcelona. · Ramon y Cajal University Hospital, Madrid. · IOB Institute of Oncology, Quiron Group, Barcelona, Spain. · Pubmed 30475950
  • Department of Medicine, Perlmutter Cancer Center, New York University School of Medicine, New York, USA. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, USA. · Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Dipartimento di Senologia, Istituto Nazionale Tumori - "Fondazione Pascale," Naples, Italy. · Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago. · Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa. · Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. · Breast Disease Research Group, The Christie NHS Foundation Trust, Manchester, UK. · Department of Oncology, Mayo Clinic, Rochester, USA. · Aichi Cancer Center Hospital, Nagoya, Japan. · Division of Oncology, Sourasky Medical Center (Ichilov), Tel Aviv, Israel. · Department of Gynecology and Obstetrics, University Carl Gustav Carus, TU Dresden, Dresden, Germany. · Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco. · Levine Cancer Institute, Atrium Health, Charlotte. · Merck & Co., Inc., Kenilworth, USA. · Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University London, London, UK. · Pubmed 30475947
  • 1Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA USA. · 0000 0001 2297 6811 · grid.266102.1 · 2Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA USA. · 3Department of Pathology, University of California San Francisco, San Francisco, CA USA. · Pubmed 31240240
2018
  • European School of Oncology (ESO), European Society for Medical Oncology (ESMO) and Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. · European Society for Medical Oncology (ESMO) and Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · European School of Oncology, Milan, Italy. · Europa Donna Cyprus, Nicosia, Cyprus. · Oncology Department, Clinique de Genolier, Genolier, Switzerland. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Breast Centre, Department of Obstetrics and Gynaecology, University of Munich (LMU), Munich, Germany. · Direction Office, ULACCAM (Union Latinoamericana Contra el Cáncer de la Mujer), Mexico DF, Mexico. · Department of Oncology, PURCS School of Medicine, Porto Alegre, Brazil. · Department of Oncology-Pathology, Karolinska Institute & University Hospital, Stockholm, Sweden. · European Society of Breast Cancer Specialists (EUSOMA) and Department of Medical Oncology, Nuovo Ospedale di Prato - Istituto Toscano Tumori, Prato, Italy. · CB Boers Organization, Wormer, The Netherlands. · Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation and Nova Medical School, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, USA. · Department of Oncology, Vall d' Hebron University, Barcelona, Spain. · Division of Early Drug Development, Department of Oncology and Hemato-Oncology, European Institute of Oncology, University of Milano, Milano, Italy. · Gynaecology and Breast Department, Centre Eugène Marquis, Rennes, France. · Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Breast Cancer Department, Cancer Institute Ion Chiricuta, Cluj-Napoca, Romania. · SHORE-C, Brighton & Sussex Medical School, University of Sussex, Brighton, UK. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · Medical Oncology Department, BC Cancer Agency, Vancouver, Canada. · Department of Medicine, The Royal Marsden, Sutton, UK. · Department of Oncology, Sheba Medical Center, Ramat Gan, Israel. · Department of Medical Oncology, Bombay Hospital Institute of Medical Sciences, Mumbai, India. · Breast Oncology Center Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Advocacy Department, UWOCASO (Uganda Women's Cancer Support Organization), Kampala, Uganda. · European Society of Radiation Oncology (ESTRO) and Department of Experimental Clinical Oncology & Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. · Cancer Institute Hospital, Breast Oncology Centre, Tokyo, Japan. · Institute of Oncology of Southern Switzerland, Geneva University Hospitals, Swiss Group for Clinical Cancer Research (SAKK), International Breast Cancer Study Group (IBCSG), Bellinzona, Switzerland. · Oncology Institute, Shaare Zedek Medical Centre, Jerusalem, Israel. · Department of Pathology, Centre Jean Perrin, Clermont-Ferrand Cedex, France. · IDIBAPS (Institut d'Investigacions Biomèdiques August Pi iSunyer), Hospital Clínic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumor, Barcelona, Spain. · Breast Oncology Clinical Trials Education, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Oncology Division, Stanford University Medical Center, Stanford, USA. · Policy Department, Breast Cancer Network Australia, Camberwell, VIC, Australia. · Department of Gynaecology, Martin Luther University Halle-Wittenburg, Halle, Germany. · Oncology Department, Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York. · Dana-Farber Cancer Institute, Susan Smith Center for Women's Cancers, Breast Oncology Center, Boston, USA. · Pubmed 30032243
  • University of California San Francisco Comprehensive Cancer Center, USA. Electronic address: · Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology, Barcelona, Spain; IOB Institute of Oncology, Quiron Group, Madrid & Barcelona, Spain. · Pubmed 29680363
  • Cleveland Clinic, Cleveland, USA. · Hematology Oncology Associates, Lake Worth, FL, USA. · University of Sheffield, Sheffield, UK. · University of Colorado, Denver, CO, USA. · Mayo Clinic, Rochester, USA. · Loyola University, Maywood, USA. · University of Cincinnati, Cincinnati, USA. · University of Miami, Deerfield Beach, FL, USA. · University of Florida, Orlando, FL, USA. · Stanford University, Stanford, USA. · University of California, San Francisco, USA. · University of Tennessee, Knoxville, USA. · Memorial Sloan Kettering, New York City, USA. · Pubmed 29352368
  • a Division of Hematology and Oncology , Massachusetts General Hospital , Boston , MA , USA. · b Division of Hematology and Oncology , University of California San Francisco, Helen Diller Family Comprehensive Cancer Center , San Francisco , CA , USA. · Pubmed 29192520
  • University of California, Los Angeles, 10945 Le Conte Avenue PVUB 3360, Los Angeles, CA, 90095, USA. Electronic address: · Pfizer Inc., 525 Market Street, 36th Floor, San Francisco, CA, 94105, USA. Electronic address: · The Royal Marsden Hospital-The Royal Marsden NHS Foundation Trust, Fulham Road, Chelsea, London, SW3 6JJ, UK. Electronic address: · Stanford University School of Medicine, 900 Blake Wilbur Drive, 1st Floor, Palo Alto, CA, 94304, USA. Electronic address: · University of California San Francisco Comprehensive Cancer Center, 1600 Divisadero Street, 3rd Floor, San Francisco, CA, 94115, USA. Electronic address: · Centre Oscar Lambret, 3 Rue Frédéric Combemale, 59000, Lille, France. Electronic address: · Klinikum Rechts der Isar, Technische Universität München, Ismaningerstrasse 22, 81675, Munich, Germany. Electronic address: · Universitäts-Frauenklinik Calwerstr. 7, 72076, Tübingen, Germany; Eberhard Karls University, Geschwister-Scholl-Platz, 72074, Tübingen, Germany. Electronic address: · Banner MD Anderson Cancer Center, 2946 E Banner Gateway Dr, Gilbert, AZ, 85234, USA. Electronic address: · Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology, CELLEX CENTER, C/ Natzaret, 115-117, 08035, Barcelona, Spain. Electronic address: · University Hospital Erlangen, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Universitätsstraße 21-23, 91054 Erlangen Erlangen, Germany. Electronic address: · Pfizer Inc., 525 Market Street, 36th Floor, San Francisco, CA, 94105, USA. Electronic address: · Pfizer Inc., 525 Market Street, 36th Floor, San Francisco, CA, 94105, USA. Electronic address: · Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA. Electronic address: · The NIHR Manchester Clinical Research Facility at The Christie & Division of Cancer Sciences University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. Electronic address: · Pubmed 30359909
  • From the Barts Cancer Institute, Queen Mary University of London, London (P.S.) · Perlmutter Cancer Center, New York University School of Medicine, New York (S.A.) · the Department of Medicine, University of California, San Francisco, San Francisco (H.S.R.), and Genentech, South San Francisco (L.M., S.Y.C., R.F.) - both in California · University Hospital Heidelberg, Heidelberg, Germany (A.S.) · Centro de Pesquisa em Oncologia, Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre (C.H.B.), and the University of São Paulo, São Paulo (R.H.) - both in Brazil · Aichi Cancer Center Hospital, Nagoya, Japan (H.I.) · the Department of Medical Oncology, Institut Curie, Paris (V.D.) · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.) · Florida Cancer Specialists and Research Institute, New Port Richey (G.S.W.) · Roche, Basel, Switzerland (V.H., A.H.) · Dana-Farber Cancer Institute, Boston (E.P.W.) · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S.L.) · and the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore (L.A.E.). · Pubmed 30345906
  • Department of Medicine (Hematology/Oncology), University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. Electronic address: · Department of Medical Oncology, Institut Claudius Regaud, Toulouse, France. · Department of Oncology and Hematology, Kaiser Permanente, Oakland, CA. · Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea. · Division of Oncology, Hospital of Oncologia Maria Curie, Cuidad de Buenos Aires, Argentina. · R-Pharm JSC, Moscow, Russian Federation. · R-Pharm US, Princeton, NJ. · Breast Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 30153978
  • Department of Obstetrics and Gynecology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Pfizer Inc., San Francisco, USA. · Seoul National University Hospital, Seoul, Korea. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · University of California, Los Angeles, USA. · Institut Paoli-Calmettes, Marseille, France. · Kaiser Permanente, Northern California, Vallejo, USA. · Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel. · Banner Health, Phoenix, USA. · Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, GEICAM, Universidad Complutense, Madrid, Spain. · Institut Universitaire du Cancer Toulouse, Toulouse, France. · Samsung Medical Center, Seoul, Korea. · Pfizer Inc., New York, USA. · Interdisziplinäres Onkologisches Zentrum München, Munich, Germany. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas. · MD Anderson Cancer Center, Houston, USA. · Pubmed 30124753
  • Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Washington University School of Medicine, St Louis, MO, USA. · Oncology & Hematology Associates of Southwest Virginia, Inc, Salem, VA, USA. · Sarah Cannon Research Institute and Tennessee Oncology PLLC, Nashville, TN, USA. · Florida Cancer Specialists, St. Petersburg, FL, USA. · Columbia University Medical Center, New York, NY, USA. · Northside Hospital, Inc, Atlanta, GA, USA. · Rocky Mountain Cancer Centers, Aurora, CO, USA. · Incyte Corporation, Wilmington, DE, USA. · University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. · Pubmed 29675680
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Department of Medical Oncology, Institut Claudius Regaud, Oncolpole-Toulouse, France. · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Division of Medical Oncology, UHN Princess Margaret Cancer Centre, Toronto, ON, Canada. · Breast and GYN Early Trials Program, Scottsdale Healthcare Shea Medical Center, Scottsdale, Arizona. · Department of Drug Development and Innovation, Institut Curie, Paris & Saint-Cloud, France, INSERM U900 Research Unit, Saint-Cloud France, and Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France. · Department of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Drug Development Department, Gustave Roussy, Villejuif, France. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Department of Clinical Oncology, Merck & Co., Inc., Kenilworth, New Jersey. · Division of Medical Oncology, Department of Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey. · Pubmed 29559561
  • German Breast Group, Neu-Isenburg, Germany; Centre for Haematology and Oncology Bethanien, Frankfurt, Germany. Electronic address: · Baylor University Medical Center, Dallas, TX, USA. · HELIOS Klinikum Berlin-Buch, Berlin, Germany. · Women & Infants Hospital of Rhode Island, Providence, RI, USA. · University of California San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · AbbVie Inc, North Chicago, IL, USA. · Ulm University, Ulm, Germany. · Brigham and Women's Hospital, Boston, MA, USA. · German Breast Group, Neu-Isenburg, Germany. · National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA. · Texas Oncology, US Oncology, Dallas, TX, USA. · Alicante University General Hospital, ISABIAL, GEICAM (Spanish Breast Cancer Research Group), Alicante, Spain. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA; Magee-Womens Hospital, Pittsburgh, PA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA; Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · Pubmed 29501363
  • Dejan Juric, Massachusetts General Hospital Cancer Center, Boston · Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA · Jordi Rodon and Josep Tabernero, Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona · Marta Gil-Martin, Catalan Institute of Oncology - Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain · Filip Janku, The University of Texas MD Anderson Cancer Center, Houston, TX · Howard A. Burris, Sarah Cannon Research Institute and Tennessee Oncology · Jordan Berlin, Vanderbilt-Ingram Cancer Center, Nashville, TN · Jan H.M. Schellens, Netherlands Cancer Institute, Amsterdam, the Netherlands · Mark R. Middleton, National Institute for Health Research, Oxford Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom · Martin Schuler, West German Cancer Center, University Duisburg-Essen, and German Cancer Consortium, Partner Site University Hospital Essen, Essen · Ruth Seggewiss-Bernhardt, Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany · Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA · Douglas Bootle, David Demanse, Lars Blumenstein, and Cornelia Quadt, Novartis Pharma AG, Basel, Switzerland · Christina Coughlin, Novartis Pharmaceuticals Corporation, East Hanover, NJ · and José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 29401002
  • Department of Medicine (Hematology/Oncology), University of California San Francisco Comprehensive Cancer Center, San Francisco, USA. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, British Columbia Cancer Agency-Vancouver Centre, Vancouver, Canada. · Division of Hematology/Oncology, University of California, Los Angeles, USA. · Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón, GEICAM, Universidad Complutense, Madrid, Spain. · Department of Oncology, Universitair Ziekenhuis Leuven-Campus Gasthuisberg, Leuven, Belgium. · Department of Chemotherapy, Lviv State Oncologic Regional Treatment and Diagnostic Center, Lviv, Ukraine. · Global Product Development, Clinical, Pfizer s.r.l., Milan, Italy. · Global Product Development, Statistics, Pfizer Inc., La Jolla, USA. · Biostatistics, Pfizer Inc., New York, USA. · Medical Affairs, Pfizer Inc., New York, USA. · Global Outcomes and Evidence, Pfizer Inc., New York, USA. · Department of Medical Oncology, The Royal Marsden NHS Foundation, London, UK. · Department of Obstetrics and Gynecology, Frauenklinik und Poliklinik Klinikum Rechts der Isar, Technische Universität München, München, Germany. · Department of Obstetrics and Gynecology, Brustzentrum der Universität München (LMU), München, Germany. · Pubmed 29360932
  • Global Product Development, Pfizer Inc., San Diego. · Pfizer Inc. · Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, California, USA. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. · Department of Obstetrics and Gynecology, Right of the Isar Hospital, Technical University of Munich, Munich, Germany. · Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco. · Pubmed 29360661
  • Division of General Internal Medicine, Department of Medicine, University of California, 1545 Divisadero St, #313, San Francisco, CA, 94143-032, USA. · The ABC Clinic, University of California, San Francisco, CA, USA. · Princeton University, Princeton, NJ, 08544, USA. · Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, CA, USA. · Institute for Health Policy Studies, University of California, San Francisco, CA, USA. · Departments of Surgery and Radiology, University of California, San Francisco, CA, USA. · Pubmed 29086230
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St, San Francisco, CA, 94115, USA. · Department of Psychology, University of Arizona, 1503 E University Blvd, Tucson, AZ, 85721, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St, San Francisco, CA, 94115, USA. · Pubmed 28921303
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital and Institute 52 Fucheng Rd, Beijing 100142, China. · Geneplus-Beijing Beijing 102206, China. · University of Chicago, Division of The Social Sciences 1130E, 59th Street, Chicago 60637, IL, USA. · Department of Medicine, University of California at San Francisco, Helen Diller Family Comprehensive Cancer Center San Francisco, USA. · Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Branch of Medical Statistics, Peking University Cancer Hospital and Institute 52 Fucheng Rd, Beijing 100142, China. · Pubmed 30323979
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, 1600 Divisidero St, San Francisco, CA 94115, USA. Electronic address: · Institute of Cancer Research and Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK. Electronic address: · David Geffen School of Medicine at UCLA, 2825 Santa Monica Blvd, Suite 200, Santa Monica, CA 90404, USA. Electronic address: · Cross Cancer Institute, 11560 University Avenue NW, Edmonton, AB T6G1Z2, Canada. Electronic address: · University of Calgary, 1403-29 St. N.W., Calgary, AB, Canada. Electronic address: · Breast Center, University of Munich (LMU), Marchioninistrasse 15, Munich 81377, Germany. Electronic address: · National Hospital Organization Osaka National Hospital, 2 Chome-1-14 Hoenzaka, Chuo, Osaka, Osaka Prefecture 540-0006, Japan. Electronic address: · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongro-gu, Seoul 03080, South Korea. Electronic address: · Pfizer Inc, 10646 Science Center Dr, San Diego, CA 92121, USA. Electronic address: · Pfizer Inc, 10646 Science Center Dr, San Diego, CA 92121, USA. Electronic address: · Pfizer Inc, 10646 Science Center Dr, San Diego, CA 92121, USA. Electronic address: · Pfizer Inc, 235 E 42nd St, New York, NY 10017, USA. Electronic address: · Pfizer Inc, 235 E 42nd St, New York, NY 10017, USA. Electronic address: · Pfizer Inc, 500 Arcola Rd, Collegeville, PA 19426, USA. Electronic address: · Institute of Cancer Research and Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK. Electronic address: · Pubmed 30053671
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco 94115, USA. · CAS Key Laboratory of Standardization and Measurement for Nanotechnology, the National Center for Nanoscience and Technology of China, Beijing 100190, China. · Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Clinical Laboratory, Peking University Cancer Hospital & Institute, Beijing 100142, China. · Pubmed 30046226
  • Department of Radiation Oncology, University of Michigan Cancer Center, Ann Arbor. · University of California, San Francisco, Comprehensive Cancer Center, San Francisco. · Pubmed 29800965
  • University of California, San Francisco, San Francisco, California. · Ramon y Cajal University Hospital, Madrid, and Vall D'Hebron Institute of Oncology, Barcelona, Spain. · Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, Texas. · University of Leeds and Leeds Teaching Hospital Trust, Leeds, United Kingdom. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. · Nektar Therapeutics, San Francisco, California. · Consultant, San Francisco, California. · ApoCell, Houston, Texas. · Nektar Therapeutics, San Francisco, California. · Mayo Clinic, Jacksonville, Florida. · Pubmed 29618616
  • Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive SRB-2, Tampa, FL 33612, USA. · Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive SRB-2, Tampa, FL 33612, USA; Cancer Biology PhD Program, University of South Florida, Tampa, FL 33620, USA. · Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive SRB-2, Tampa, FL 33612, USA; Department of Breast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA. · Department of Medicine and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA. · Department of Pathology, University of California, San Francisco, CA 94143, USA. · Department of Cell, Developmental & Cancer Biology, and Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA. · Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive SRB-2, Tampa, FL 33612, USA; Department of Breast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA. Electronic address: · Pubmed 29316433
  • Division of Hematology/Oncology, University of California at San Francisco, San Francisco, California. · Division of Hematology/Oncology, University of California at San Francisco, San Francisco, California. · Department of Laboratory Medicine, University of California at San Francisco, San Francisco, California. · Helen Diller Family Comprehensive Cancer Center and Computational Biology and Informatics, University of California at San Francisco, San Francisco, California. · Alliance Statistics and Data Center, Duke University, Durham, North Carolina. · Alliance Statistics and Data Center, Dana-Farber Cancer Institute, Boston, Massachusetts. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 29311117
  • Department of Medicine (Hematology/Oncology), Director Breast Oncology Clinical Trials Program, University of California San Francisco, San Francisco, CA. · Medical Device Consultants of Ridgewood LLC, Ridgewood, NJ. Electronic address: · Pubmed 28939291
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA. · Indiana University Medical CTR, Indianapolis, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Pubmed 27927580
  • Amy Jo Chien and Hope S. Rugo, University of California San Francisco Comprehensive Cancer Center, San Francisco, CA. · Pubmed 28783451
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University, Cancer Hospital & Institute, Beijing, 100142, China. · Pubmed 29282695
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, UCSF Medical Center at Mount Zion, 1600 Divisadero St, San Francisco, CA, 94115, USA. · Wake Forest University Baptist Medical Center, Medical Center Blvd, Fl 3, Winston Salem, NC, 27157, USA. · Medical Device Consultants Ridgewood, LLC, 99 Glenwood Rd, Ridgewood, NJ, 07450, USA. · Pubmed 28275922
  • UCSF Helen, Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA, 94115, USA. · Centre Léon Bérard, Lyon, France. · National Cancer Center, Goyang, Republic of Korea. · H. de Lleida Arnau de Vilanova, Lerida, Spain. · Institut de Cancérologie de l'Ouest, St Herblain-Nantes, France. · University Hospital of Parma, Parma, Italy. · Instituto Português de Oncologia Francisco Gentil, Porto, Portugal. · Korea University Medical Center, Seoul, Republic of Korea. · Ramón y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Merck& Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · Alexion Pharmaceuticals, New Haven, CT, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28681171
  • Center for Translational Medicine, School of Pharmacy, University of Maryland, Baltimore, Maryland, USA. · University of Chicago, Chicago, Illinois, USA. · NorthShore University Health System, Evanston, Illinois, USA. · State Key Laboratory of Natural and Biomimetic Drugs (Peking University), Beijing, China. · Alliance Statistics and Data Center, Duke University, Durham, North Carolina, USA. · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Dana-Farber/Partners CancerCare/ Harvard Cancer Center, Boston, Massachusetts, USA. · Heartland Cancer Research NCORP, St. Louis, Missouri, USA. · Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA. · Mayo Clinic, Rochester, Minnesota, USA. · John H. Stroger Jr Hospital of Cook County, Chicago, Illinois, USA. · Decatur Memorial Hospital/Cancer Care Specialists of Illinois/ Heartland Cancer Research NCORP, Decatur, Illinois, USA. · University of California-San Francisco, San Francisco, California, USA. · Center for Translational Medicine, School of Pharmacy, University of Maryland, Baltimore, Maryland, USA. · Center for Translational Medicine, School of Pharmacy, University of Maryland, 20 N Pine Street, Room 513, Baltimore, Maryland, 21201, USA. · Pubmed 28620884
  • Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. · University of California, San Francisco, 1600 Divisadero St., San Francisco, CA, 94115, USA. · Valley Medical Oncology Consultants, Stanford Health Care, 2505 Hospital Drive, Mountain View, CA, 94040, USA. · University of California, San Francisco, 1600 Divisadero St., San Francisco, CA, 94115, USA. · Pubmed 28577080
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Boston, Massachusetts. · University of California San Francisco Comprehensive Cancer Center, San Francisco, California. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Ramón y Cajal University Hospital, Madrid, Spain. · Institut Curie, Paris, France. · Texas Oncology, Austin, Texas. · Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, Texas. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center, New York, New York. · Sarah Cannon Research Institute, Tennessee Oncology PLLC, Nashville, Tennessee. · Eli Lilly and Company, Indianapolis, Indiana. · Pubmed 28533223
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St., Box 1710, San Francisco, CA, 94115, USA. · University of California San Francisco School of Medicine, Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St., Box 1710, San Francisco, CA, 94115, USA. · Columbia University College of Physicians and Surgeons, New York, NY, USA. · Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, CA, USA. · Pubmed 28503722
  • Leeds Institute of Cancer and Pathology and St James's Institute of Oncology, Leeds, UK. Electronic address: · Ramon y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Baylor-Sammons Cancer Center, Texas Oncology, U.S. Oncology, Dallas, TX, USA. · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Mayo Clinic, Jacksonville, FL, USA. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota, Department of Medicine, Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Ramon y Cajal University Hospital, Madrid, Spain. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Consultant, Sebastopol, CA, USA. · University of California, San Francisco, CA, USA. · Pubmed 28360015
  • Memorial Sloan Kettering Cancer Center, New York, NY, USA. · H. de Lleida Arnau de Vilanova, Lérida, Spain. · Institut Jules Bordet, Brussels, Belgium. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Institute of Clinical Research, Odense University Hospital, University of Southern Denmark, Odense, Denmark. · Ramon y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Massachusetts General Hospital, Boston, MA, USA. · Mayo Clinic, Rochester, MN, USA. · University of Minnesota Masonic Clinical Cancer Center, Minneapolis, MN, USA. · Hospital 12 de Octubre, Madrid, Spain. · Clinique Sainte Elisabeth, Namur, Belgium. · Merck & Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St., San Francisco, CA, USA. · Pubmed 28324268
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. Electronic address: · Los Angeles Cancer Network, Los Angeles, CA, USA. · Highlands Oncology Group, Fayetteville, AR. · University of California Los Angeles School of Medicine, Los Angeles, CA, USA. · Oncology Consultants PA, Department of Research, Houston, TX, USA. · St Luke's Cancer Institute, Kansas City, MO, USA. · Cancer Treatment Centers of America, Atlanta, GA, USA. · Kaiser Permanente Mid-Atlantic States, Gaithersburg, MD, USA. · UC Irvine Health Chao Family Comprehensive Cancer Center, Orange, CA, USA. · Vanderbilt-Ingram Comprehensive Cancer Center, Nashville, TN, USA. · Oncology and Diagnostic Sciences, Dental School and The Marlene and Stewart Greenebaum Comprehensive Cancer Center University of Maryland Medical Center, Baltimore, MD, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Pubmed 28314691
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco. · Biocon Research Limited, Bangalore, India3Now with Mylan Inc, Canonsburg, Pennsylvania. · Department of Haematology, Oncology, and Stem Cell Transplantation, University Medical Centre Freiburg and Faculty of Medicine, University of Freiburg, Freiburg, Germany. · Quiron-Dexeus, Barcelona, Spain. · Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland. · Mylan Inc, Canonsburg, Pennsylvania. · Biocon Research Limited, Bangalore, India. · City Clinical Oncology Dispensary, Saint Petersburg, Russia. · Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine. · Regional Clinical Oncological Center, Kazan, Russia. · Institute of Clinical Oncology, Tbilisi, Georgia. · St Luke's Medical Center Global City, Taguig City, Philippines. · Cardinal Santos Medical Center, Manila, Philippines. · Golden Fleece 21 Century Health House Ltd, Tbilisi, Georgia. · Siriraj Hospital, Bangkok, Thailand. · Sumy State University, Sumy, Ukraine. · King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand. · City Cancer Center, Vijayawada, India. · Curie Manavata Cancer Centre, Nasik, India. · Instituto Clinico Oncologico del Sur, Temuco, Chile. · Pubmed 27918780
  • Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco. · Samuel Merritt University, Oakland, California. · Pubmed 27832260
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 28949948
  • Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco. · Pubmed 28727874
  • University of California-San Francisco Comprehensive Cancer Center, San Francisco. · Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 28715579
  • Ramon y Cajal University Hospital, Madrid, Spain, and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · University of California, San Francisco, CA, USA. · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Leeds Institute of Cancer and Pathology and St James's University Hospital, Leeds, UK. · Mayo Clinic, Jacksonville, FL, USA. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · , The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · Department of Medicine, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Consultant, Sebastopol, CA, USA. · Texas Oncology-Baylor Charles A. Sammons Cancer Center/U.S. Oncology, 3410 Worth Street, Suite 400, Dallas, TX, 75246, USA. · Pubmed 28612225
  • Executive Vice Chair, Surgery; Associate Director, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA. · Professor of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA. · Vice President, Healthcare Outcomes and Policy, Roswell Park Cancer Institute, Buffalo, NY. · Associate Professor, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Medicine; Director, Breast Oncology and Clinical Trials Education, University of California, San Francisco, San Francisco, CA. · Chairman, Department of Radiation Oncology, Albert Einstein Healthcare Network, Philadelphia, PA. · Professor of Pathology, University of Vermont, Burlington, VT. · Associate Director, Kellogg Cancer Surgical Services, NorthShore University HealthSystem, Evanston, IL. · Professor; Co-Director, Breast Cancer Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 28294295
  • University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, 94115, USA. Electronic address: · Helsinn Healthcare SA, 6912, Pazzallo, Lugano, Switzerland. · IMO Clinique de Genolier, CH-1272, Genolier, Vaud, Switzerland. · Pubmed 28285236
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco. · Icahn School of Medicine at Mount Sinai, New York, New York. · Wake Forest Baptist Health Medical Center, Wake Forest School of Medicine, Winston-Salem, North Carolina. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles. · Weill Cornell Medical College, New York, New York. · Target Health Inc, New York, New York. · Dignitana AB, Lund, Sweden. · Wake Forest School of Medicine, Winston-Salem, North Carolina. · Columbia University, New York, New York10Now with the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. · Pubmed 28196257
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 29200414
2016
  • Hope S. Rugo, University of California San Francisco Comprehensive Cancer Center · Barbara Fowble, University of California San Francisco, San Francisco · Rita S. Mehta, University of California Irvine, Orange, CA · R. Bryan Rumble, American Society of Clinical Oncology, Alexandria · James L. Khatcheressian, Virginia Cancer Institute, Richmond, VA · Erin Macrae, Columbus Oncology and Hematology Associates, Columbus, OH · Debra L. Barton, University of Michigan School of Nursing, Ann Arbor, MI · Hannah Klein Connolly, Patient Representative, Edina, MN · Maura N. Dickler, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY · Lesley Fallowfield, Sussex Health Outcomes Research and Education in Cancer, Brighton and Sussex Medical School, University of Sussex, Sussex · Stephen R.D. Johnston, Royal Marsden Hospital, London, United Kingdom · James N. Ingle, Mayo Clinic, Rochester, MN · Mohammad Jahanzeb, University of Miami Sylvester Comprehensive Cancer Center, Deerfield Beach, FL · Larissa A. Korde, University of Washington, Seattle, WA · Hyman B. Muss, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC · and Harold J. Burstein, Dana-Farber Cancer Center, Boston, MA. · Pubmed 27217461
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD · University of California San Francisco Comprehensive Cancer Center, San Francisco, CA. · Pubmed 27185850
  • School of Dental Medicine and Neag Comprehensive Cancer Center, UConn Health, Farmington, Connecticut. · Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Eastman Institute for Oral Health, University of Rochester Medical Center, Rochester, New York. · Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York. · School of Dentistry, University of Washington and Seattle Cancer Care Alliance, Seattle, Washington. · New York University College of Dentistry, New York, New York. · Penn State Hershey Medical Center, Hershey, Pennsylvania. · Tennessee Oncology/Sarah Cannon Research Institute, Nashville, Tennessee. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California. · School of Dentistry and the Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland. · Pubmed 27334013
  • From the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of San Francisco School of Medicine, San Francisco, CA; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO. · Pubmed 27249746
  • University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. Electronic address: · Pubmed 26507507
  • Division of Hematology-Oncology, University of California, San Francisco, San Francisco, CA. · Division of Hematology-Oncology, University of California, San Francisco, San Francisco, CA. Electronic address: · Pubmed 26303211
  • From the Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at the University of California, Los Angeles, Santa Monica (R.S.F., D.J.S.) · the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco (H.S.R.) · and Pfizer, La Jolla (E.G., D.R.L., S.R.) - all in California · Hospital Gregorio Maranon, Universidad Complutense, Madrid (M.M.) · U.S. Oncology Research, The Woodlands, TX (S.J.) · Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.) · British Columbia Cancer Agency, Vancouver, Canada (K.G.) · Brustzentrum der Universität München (LMU), Munich, Germany (N.H.) · State Budget Medical Institution Republican Clinical Oncology, Ufa, Russia (O.N.L.) · All-Ireland Cooperative Oncology Research Group, Dublin (J.M.W.) · M.D. Anderson Cancer Center, University of Texas, Houston (S.M.) · and Institut Curie, Paris (V.D.). · Pubmed 27959613
  • University of Calgary, Alberta, Canada · Pfizer Inc., Collegeville, Pennsylvania, USA. · Pfizer Inc., New York, New York, USA. · University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · National Cancer Center, Goyang-si, Republic of Korea. · Istituto Europeo di Oncologia, Milan, Italy. · Aichi Cancer Center Hospital, Nagoya, Japan. · Brustzentrum der Universität München, Munich, Germany. · Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois, USA. · Pfizer Inc., San Diego, California, USA. · Pfizer Inc., Cambridge, Massachusetts, USA. · Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Pubmed 27368881
  • Maura N. Dickler, Mary Ellen Moynahan, Diana E. Lake, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY · William T. Barry, Dana-Farber Cancer Institute · Eric P. Winer, Dana-Farber/Partners Cancer Care, Boston, MA · Constance T. Cirrincione, Duke University, Durham, NC · Matthew J. Ellis, Baylor College of Medicine · Debasish Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX · Federico Innocenti and Lisa A. Carey, University of North Carolina at Chapel Hill, Chapel Hill, NC · Arti Hurria, City of Hope, Duarte · Hope S. Rugo, University of California at San Francisco, San Francisco, CA · Olwen Hahn, Alliance for Clinical Trials in Oncology, Chicago, IL · and Bryan P. Schneider, Indiana University School of Medicine, Indianapolis, IN. · Pubmed 27138575
  • Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St, Box 1710, San Francisco, CA, 94115, USA. · Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St, Box 1710, San Francisco, CA, 94115, USA. · Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc, Kenilworth, NJ, USA. · Merck Research Laboratories, North Wales, PA, USA. · Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Laboratory Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, Sanfrancisco, CA, USA. · Pubmed 26875185
  • Department of Cell and Tissue Biology, University of California, San Francisco (UCSF), San Francisco, California, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA. · Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA. · Department of Surgery, University of California, San Francisco, San Francisco, California, USA. · Cancer and Developmental Therapeutics Program, Buck Institute for Research on Aging, Novato, California, USA. · Department of Anatomy, University of California, San Francisco, San Francisco, California, USA. · Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, USA. · Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, USA. · Department of Medicine, University of California, San Francisco, San Francisco, California, USA. · Pubmed 27775705
  • Ramon y Cajal University Hospital, Madrid, Spain ; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron 119-129, Barcelona, Spain. · University of California, San Francisco, CA USA. · St. James's University Hospital, University of Leeds, Leeds, UK. · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Mayo Clinic, Jacksonville, FL USA. · Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. · Nektar Therapeutics, San Francisco, CA USA. · Consultant, Sebastopol, CA USA. · Baylor-Sammons Cancer Center, Texas Oncology, U.S. Oncology, Dallas, TX USA. · Pubmed 27441152
  • Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA. · Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, IL, USA. · Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · Department of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA. · Department of Medical Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Pubmed 27224917
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA. Electronic address: · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA. · Pubmed 26874902
  • Dana-Farber Cancer Institute, Boston, MA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Massachusetts General Hospital, Boston, MA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26868124
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco · The University of Texas MD Anderson Cancer Center, Houston, USA. · Charité Universitätsmedizin Berlin/Campus Virchow-Klinikum, Berlin, Germany. · Hôpital Saint-André, Bordeaux University Hospital, Bordeaux, France. · University of Cincinnati College of Medicine, Cincinnati, USA. · Novartis Pharma AG, Basel, Switzerland. · Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 26759276
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, West Harrison, New York. · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Breast Cancer Research, Sarah Cannon Research Institute, Nashville, Tennessee. · Department of Medicine, Duke University Medical Center, Durham, North Carolina. · Department of Medicine, Cardinal Bernardin Cancer Center, Loyola University Chicago, Chicago, Illinois. · Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco. · Department of Medicine, Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis. · Department of Medicine, Washington University School of Medicine, St Louis, Missouri. · Department of Hematology Oncology, Hofstra North Shore-Long Island Jewish School of Medicine, Hempstead, New York. · Department of Oncology, The Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland. · Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill. · Department of Medicine, Massachusetts General Hospital, Boston. · Department of Medicine, Cardio-Oncology Program, Vanderbilt School of Medicine, Nashville, Tennessee. · Pubmed 26539793
  • Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX · David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ · Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels · Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium · Hope S. Rugo, University of California, San Francisco · Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA · Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada · Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain · Thomas Bachelot, Centre Léon Bérard, Lyon, France · Shinzaburo Noguchi, Osaka University Medical School · Norikazu Masuda, Osaka National Hospital, Osaka, Japan · Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL · Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ · Shaker Dakhil, Cancer Center of Kansas, Wichita, KS · Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA · and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 26503204
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 27379943
2015
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China. · University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St, Box 1710 San Francisco CA 94115, USA. · Pubmed 26557900
  • Mayo Clinic, Jacksonville, FL, USA. Electronic address: · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Baylor-Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · University of California, San Francisco, CA, USA. · University of Leeds and St James's University Hospital, Leeds, UK. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota Department of Medicine and Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Mayo Clinic, Jacksonville, FL, USA. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Sebastopol, CA, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain; Ramon y Cajal University Hospital, Madrid, Spain. · Pubmed 26482278
  • Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA · William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute · Erica L. Mayer and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA · Alvaro Moreno-Aspitia and Edith A. Perez, Mayo Clinic, Jacksonville, FL · Alan P. Lyss, Heartland Cancer Research Community Clinical Oncology Program · Michael Naughton, Washington University School of Medicine, St Louis, MO · Constance Cirrincione and Eleanor Leung, Alliance Statistics and Data Center, Duke University, Durham · Lisa A. Carey, University of North Carolina, Chapel Hill, NC · Deborah Toppmeyer, Cancer Institute of New Jersey, New Brunswick, NJ · and Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26056183
  • Steven J. Isakoff, Lei He, Darrel R. Borger, Dianne M. Finkelstein, Paula D. Ryan, Paul E. Goss, and Leif W. Ellisen, Massachusetts General Hospital Cancer Center · Steven J. Isakoff, Erica L. Mayer, Lei He, Karen Krag, Steven E. Come, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, and Leif W. Ellisen, Harvard Medical School · Erica L. Mayer, Judy E. Garber, and Eric P. Winer, Dana-Farber Cancer Institute · Steven E. Come, Beth Israel Deaconess Medical Center, Boston · Karen Krag, Massachusetts General Hospital/North Shore Cancer Center, Danvers, MA · Tiffany A. Traina, Memorial Sloan Kettering Cancer Center, New York, NY · Lisa A. Carey, The University of North Carolina at Chapel Hill, Chapel Hill, NC · Hope S. Rugo, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA · Minetta C. Liu, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC · Vered Stearns, The Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Kirsten Timms, Myriad Genetics · and Anne-Renee Hartman, Myriad Genetic Laboratories, Salt Lake City, UT. · Pubmed 25847936
  • University of Alabama at Birmingham, Birmingham, Alabama. · HudsonAlpha Institute for Biotechnology, Huntsville, Alabama. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · University of Alabama at Birmingham, Birmingham, Alabama. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Georgetown University Hospital, Washington, District of Columbia. · University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · The University of Chicago, Chicago, Illinois. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana. · Memorial Sloan-Kettering Cancer Center, New York, New York. · University of Michigan, Ann Arbor, Michigan. · Baylor College of Medicine, Houston, Texas. · University of North Carolina, Chapel Hill, North Carolina. · Mayo Clinic College of Medicine, Rochester, Minnesota. · Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, Maryland. · Pubmed 25779953
  • From the Departments of Medical Oncology (S.M.T., B.A.O., A.H.P., I.E.K., H.J.B., E.P.W.) and Biostatistics and Computation Biology (W.T.B., H.G.), Dana-Farber Cancer Institute, and Department of Hematology-Oncology, Massachusetts General Hospital (B.M.) - both in Boston · Breast Cancer Medicine Service, Department of Medicine, Solid Tumor Division, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical Center, New York (C.T.D., C.A.H.), and Department of Medical Oncology, Hofstra North Shore-LIJ School of Medicine, New Hyde Park (I.S.) - all in New York · Sarah Cannon Cancer Center, Department of Medical Oncology, Nashville (D.A.Y.) · Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham (P.K.M.), and Department of Medical Oncology, University of North Carolina, Chapel Hill (L.A.C.) - both in North Carolina · Cardinal Bernardin Cancer Center, Department of Medicine, Division of Hematology-Oncology, Loyola University Chicago Stritch School of Medicine, Maywood, IL (K.S.A.) · Comprehensive Cancer Center, Department of Medicine, Division of Oncology, University of California, San Francisco, San Francisco (H.S.R.) · Department of Medical Oncology, Washington University in St. Louis, St. Louis (M.E.) · and Johns Hopkins Kimmel Cancer Center, Department of Oncology, Baltimore (A.C.W.). · Pubmed 25564897
  • Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Pubmed 26520840
  • Division of Hematology-Oncology, University of California San Francisco, San Francisco, CA, 94115, United States of America. · Siemens Healthcare Diagnostics, Elkhart, IN, 46516, United States of America. · Pubmed 26496203
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Buck Institute for Research on Aging, Novato, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Department of Urology, University of California San Francisco, San Francisco, CA, USA. · UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA. · Pubmed 26021444
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Division of, Medical Oncology, Department of Medicine, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Department of Medical Oncology, Baptist Cancer Center, Memphis, Tennessee. · Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25757412
  • University of Pennsylvania, Philadelphia, Pennsylvania. · University of Minnesota, Minneapolis, Minnesota. · University of Texas MD Anderson Cancer Center, Houston, Texas. · Loyola University Medical Center, Maywood, Illinois. · Buck Institute for Research on Aging, Novato, California. · Mayo Clinic, Rochester, Minnesota. · University of California, San Francisco, San Francisco, California. · British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Oregon Health and Science University, Portland, Oregon. · Inova Fairfax Hospital Cancer Center, Fairfax, Virginia. · University of Colorado Denver, Denver, Colorado. · University of Alabama at Birmingham, Birmingham, Alabama. · University of Texas Southwestern, Dallas, Texas. · Georgetown University Medical Center, Washington, DC. · Swedish Cancer Institute, Seattle, Washington. · University of Washington, Seattle, Washington. · Emory University, Atlanta, Georgia. · H. Lee Moffitt Cancer Center, Tampa, Florida. · University of Chicago, Chicago, Illinois. · QuantumLeap Healthcare Collaborative, San Francisco, California. · University of California, San Diego, San Diego, California. · Gemini Group Ann Arbor, Michigan. · George Mason University, Fairfax County, Virginia. · University of Southern California, Los Angeles, California. · University of Arizona Cancer Center, Tucson, Arizona. · University of California, San Francisco, San Francisco, California. · Pubmed 25712686
  • Antonio C. Wolff, Amanda L. Blackford, Kala Visvanathan, Terry S. Langbaum, and Judith E. Karp, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Hope S. Rugo, University of California, San Francisco Comprehensive Cancer Center, San Francisco, CA · Beverly Moy, Massachusetts General Hospital Cancer Center · Melissa E. Hughes and Jane C. Weeks, Dana-Farber Cancer Institute, Boston, MA · Lori J. Goldstein, Fox Chase Cancer Center, Philadelphia, PA · Keith Stockerl-Goldstein, Siteman Cancer Center at Washington University School of Medicine, St Louis, MO · Leigh Neumayer, Huntsman Cancer Center at University of Utah School of Medicine, Salt Lake City, UT · and Richard L. Theriault, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 25534386
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina. · Baylor University College of Medicine, Houston, Texas. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Duke University Medical Center, Durham, North Carolina. · Georgetown University, Washington, District of Columbia. · Laura & Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, New York. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 25524311
  • Augmentium Pharma Consulting Inc, Toronto, Ontario, Canada. Electronic address: · Sylvester Comprehensive Care Center, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida. · Eisai Inc, Woodcliff Lake, New Jersey. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Pubmed 25433768
  • Division of Hematology-Oncology, University of California San Francisco, San Francisco, California. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 25351747
  • Department of Radiation Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA. Electronic address: · Department of Radiation Medicine and Applied Sciences, University of California San Diego Moores Cancer Center, San Diego, CA. · Athena Breast Health Network, San Francisco, CA. · Department of Medicine (Hematology/Oncology), University of California Helen Diller Comprehensive Cancer Center, San Francisco, CA. · Department of Surgical Oncology, Duke University, Durham, NC. · Department of Surgical Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA. · Department of Radiation Oncology, University of California Irvine, Orange, CA. · Department of Radiation Oncology, Ronald Reagan UCLA Medical Center, UCLA Medical Center, Santa Monica, Santa Monica, CA. · Department of Radiation Oncology, University of California Helen Diller Comprehensive Cancer Center, San Francisco, CA. · Pubmed 25245425
2014
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, Arome, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, DE, USA. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · Advanced BC.org, New York, USA. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25244983
  • From the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco. · Pubmed 25006724
  • Joyce O'Shaughnessy, Baylor Charles A. Sammons Cancer Center, Texas Oncology · Joyce O'Shaughnessy, US Oncology, Dallas · Beth Hellerstedt Texas Oncology-Round Rock, Austin, TX · Lee Schwartzberg, Accelerated Community Oncology Research Network · Lee Schwartzberg, The West Clinic, Memphis · Denise A. Yardley, Sarah Cannon Research Institute · Denise A. Yardley, Tennessee Oncology, Nashville, TN · Michael A. Danso, US Oncology · Michael A. Danso, Virginia Oncology Associates, Norfolk · Nicholas Robert, Virginia Cancer Specialists, Fairfax · Paul Richards, Blue Ridge Cancer Care, Salem, VA · Kathy D. Miller, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN · Hope S. Rugo, University of California, San Francisco Comprehensive Cancer Center, San Francisco · Robert W. Carlson, Stanford Comprehensive Cancer Center, Palo Alto, CA · Richard S. Finn, Geffen School of Medicine at University of California, Los Angeles · Richard S. Finn, Translational Research in Oncology, Los Angeles, CA · Marcus Neubauer, Kansas City Cancer City, Overland Park, KS · Mansoor Saleh, Georgia Cancer Specialists, Sandy Springs, GA · Jennifer M. Specht, University of Washington, Seattle Cancer Care Alliance, Seattle, WA · Eric Charpentier, Ignacio Garcia-Ribas, Sanofi, Cambridge · and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 25349301
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Department of Breast Medical Oncology, Multidisciplinary Breast Cancer Research Program, University of Texas MD Anderson Cancer Center, Houston, USA. · Institut de Cancérologie de l'Ouest, René Gauducheau, Centre de Recherche en Cancérologie, Nantes Saint Herblain, France. · Department of Medicine, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo. · Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. · Breast Cancer Centers, Memorial Cancer Institute, Hollywood. · Breast Oncology and Clinical Trials Education, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Oncologic Centre, AZ Nikolaas, Sint-Niklaas, Belgium. · Sarah Cannon Research Institute, Nashville, USA. · Centre des Maladies du Sein Deschênes-Fabia, CHU-Hôpital du Saint Sacrement, Québec, Canada. · Multidisciplinary Breast Centre and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Ironwood Cancer & Research Centers, Chandler. · Novartis Pharmaceuticals Corporation, East Hanover. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 25231953
  • A. Jo Chien, Pamela N. Munster, Michelle E. Melisko, Hope S. Rugo, John W. Park, Andrei Goga, Glenna Auerback, Elham Khanafshar, and Mark M. Moasser, Helen Diller Family Comprehensive Cancer Center · A. Jo Chien, Pamela N. Munster, Michelle E. Melisko, Hope S. Rugo, John W. Park, Andrei Goga, Glenna Auerback, Elham Khanafshar, Karen Ordovas, and Mark M. Moasser, University of California San Francisco, San Francisco, CA · and Kevin M. Koch, GlaxoSmithKline, Research Triangle Park, NC. · Pubmed 24711549
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal · European School of Oncology, Milan, Italy European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, Denmark. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · AdvancedBC.org, New York. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25234545
  • Ines Vaz-Luis, Melissa E. Hughes, Harold J. Burstein, Jane C. Weeks, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute · Beverly Moy, Massachusetts General Hospital, Boston, MA · Ines Vaz-Luis, Instituto de Medicina Molecular, Lisbon, Portugal · Rebecca A. Ottesen and Rizvan Mamet, City of Hope, Duarte · Hope S. Rugo, University of California, San Francisco, San Francisco, CA · Stephen B. Edge, Roswell Park Cancer Institute, Buffalo, NY · Stephen B. Edge, Baptist Cancer Center, Memphis, TN · and Ana M. Gonzalez-Angulo and Richard L. Theriault, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 24888816
  • Sarah Cannon Research Institute/Tennessee Oncology, PLLC, 250 25th Avenue N, Ste 100 Nashville, TN 37203, USA. · Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, Los Angeles, CA 90033, USA. · University of Pittsburgh Cancer Institute, 200 Lothrop Street, Pittsburgh, PA 15213, USA. · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA 94115, USA. · Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, One Medical Center Dr, Lebanon, NH 03756, USA. · AdvancedBC.org 250 West 82 Street, #42, New York, NY 10024, USA. · Statistical Innovations Inc, 375 Concord Avenue, Belmont, MA 02478, USA. · Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA. · 1] EpiSource, LLC, 53 Fenwick Road, Waban, MA 02468, USA [2] Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118, USA. · Pubmed 24743708
  • University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, USA. · Pubmed 24615500
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA · Institut Multidisciplinaire D'Oncologie, Genolier, Switzerland. · Pubmed 25085504
2013
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143-0875, USA. · Pubmed 23649189
  • University of California San Francisco, San Francisco, California. · Pubmed 24892840
  • University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 24637554
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, Box 1710, San Francisco, CA, 94143-1710, USA, · Pubmed 24062208
2018
  • From the University of Texas M.D. Anderson Cancer Center, Houston (J.K.L.), and the Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas (J.L.B.) - both in Texas · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (H.S.R.), and Pfizer (R.G.W.Q., D.M., I.C.T., A.L.H.), San Francisco, University of California, Los Angeles, Los Angeles (S.A.H.), and Kaiser Permanente, Northern California, Vallejo (L.F.) - all in California · the Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technische Universität München (J.E.), and Interdisziplinäres Onkologisches Zentrum München (W.E.) - both in Munich, Germany · Institut Paoli-Calmettes, Marseille (A.G.), and Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulouse (H.R.) - both in France · Seoul National University Hospital (K.-H.L.) and Samsung Medical Center (Y.-H.I.) - both in Seoul, South Korea · Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel (R.Y.) · Banner M.D. Anderson Cancer Center, Gilbert, AZ (L.A.M.) · and Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Oncología, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid (M.M.). · Pubmed 30110579
2016
  • aDepartment of Medical Oncology, Dubai Hospital, UAE bUniversity of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. · Pubmed 27755140
  • From University of California, San Francisco (UCSF) (H.S.R., C.Y., L.J.V., M.B.B., N.M.H., A.J.C., C.E., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California San Diego, San Diego (A.M.W., R.S.), and University of Southern California, Los Angeles (D.T.) - all in California · University of Chicago (O.I.O., R.N.), and Loyola University (K.S.A.), Chicago · University of Pennsylvania, Philadelphia (A.D.) · Gemini Group, Ann Arbor, MI (J.P.) · University of Texas M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), UT Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas · University of Minnesota, Minneapolis (D.Y.), and Mayo Clinic, Rochester (J.C.B., T.C.H.) - both in Minnesota · Swedish Medical Center, Seattle (H.G.K.) · Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.) · University of Kansas, Lawrence (Q.J.K.) · University of Arizona, Tucson (J.E.L., R.K.V.), and Mayo Clinic, Scottsdale (D.W.N.) - both in Arizona · Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.) · University of Denver, Denver (A.D.E.) · Inova Fairfax Hospital, Falls Church, VA (K.K.E.) · and Emory University, Atlanta (W.C.W.). · Pubmed 27406347
2015
  • Department of Medicine, University of California, 1600 Divisadero St., Box 1710, San Francisco, CA, 94115, USA, · Pubmed 26208485
2014
2013
  • University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisidero Street, Box 1710, San Francisco, CA 94143-1710, USA. · Pubmed 23143215
  • Authors' Affiliations: Breast Cancer Medicine Service, Departments of Pathology, Biostatistics, and Radiology, Memorial Sloan-Kettering Cancer Center; Weill Medical College of Cornell University, New York; Dana-Farber Cancer Institute; Massachusetts General Hospital, Boston, Massachusetts; Mayo Clinic, Rochester, Minnesota; Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia; University of North Carolina at Chapel Hill, Chapel Hill; Duke University Medical Center, Durham, North Carolina; University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California; University of Alabama at Birmingham, Birmingham, Alabama; and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland. · Pubmed 23965901
  • Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA 94115, USA. · Pubmed 23135909
2012
  • University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, 2nd floor, San Francisco, CA 94115, USA. · Pubmed 23148612
Probable:    Miscellaneous institutions in San Francisco      
2019
  • 1Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 USA. · 0000 0004 0386 9924 · grid.32224.35 · 2University of California San Francisco, 1600 Divisadero Street, San Francisco, CA 94115 USA. · 0000 0001 2297 6811 · grid.266102.1 · 3University of California San Francisco, 1600 Divisadero Street, San Francisco, CA 94115 USA. · Pubmed 31840050
Probable:    Genentech Inc.      
2018
  • From the Barts Cancer Institute, Queen Mary University of London, London (P.S.) · Perlmutter Cancer Center, New York University School of Medicine, New York (S.A.) · the Department of Medicine, University of California, San Francisco, San Francisco (H.S.R.), and Genentech, South San Francisco (L.M., S.Y.C., R.F.) - both in California · University Hospital Heidelberg, Heidelberg, Germany (A.S.) · Centro de Pesquisa em Oncologia, Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre (C.H.B.), and the University of São Paulo, São Paulo (R.H.) - both in Brazil · Aichi Cancer Center Hospital, Nagoya, Japan (H.I.) · the Department of Medical Oncology, Institut Curie, Paris (V.D.) · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.) · Florida Cancer Specialists and Research Institute, New Port Richey (G.S.W.) · Roche, Basel, Switzerland (V.H., A.H.) · Dana-Farber Cancer Institute, Boston (E.P.W.) · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S.L.) · and the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore (L.A.E.). · Pubmed 30345906
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 155 total) written by Hope S. Rugo about Breast Neoplasms:

  • Achieving Improved Survival Outcomes in Advanced Breast Cancer. 2019
  • The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea. 2019
  • Alpelisib for 2019
  • ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases. 2019
  • Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial). 2019
  • Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer. 2019
  • Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up. 2019
  • Alpelisib Plus Fulvestrant in PIK3CA-Altered and PIK3CA-Wild-Type Estrogen Receptor-Positive Advanced Breast Cancer: A Phase 1b Clinical Trial. 2019
  • A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance). 2019
  • Androgen receptor gene expression in primary breast cancer. 2019
Show List of Full Article Records
Google Searches

Learn more about Hope S. Rugo using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of California San Francisco
Miscellaneous institutions in San Francisco
Genentech Inc.
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of California San Francisco
2019
  • From the University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco. · Pubmed 31340099
  • Department of Medicine (Hematology/Oncology), University of California San Francisco Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St., Box 1710, San Francisco, CA, 94143-1710, USA. · Division of Gastroenterology, University of South Alabama College of Medicine, 75 S. University Blvd., Mobile, AL, 36688, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe, Unit 1354, Houston, TX, 77030, USA. · Puma Biotechnology, Inc., 10880 Wilshire Blvd. Suite 2150, Los Angeles, CA, 90024, USA. · Puma Biotechnology, Inc., 701 Gateway Blvd, Suite 500, South San Francisco, CA, 94080, USA. · QED Therapeutics, 421 Kipling St, Palo Alto, CA, 94301, USA. · City of Hope Medical Group, Inc, 1500 E Duarte Rd, Duarte, CA, 91010, USA. · Pubmed 30671765
  • From Institut Gustave Roussy, INSERM Unité 981, Université Paris-Sud, Villejuif (F.A.), Institut de Cancérologie de l'Ouest, St. Herblain (M.C.), and Novartis Pharma, Paris (A.-S.L.) - all in France · Hospital Universitario 12 de Octubre, Madrid (E.C.) · National Institute of Oncology (G.R.) and Duna Medical Center (Z.P.), Budapest, Hungary · German Breast Group, Neu-Isenburg, and Center for Hematology and Oncology Bethanien, Frankfurt - both in Germany (S.L.) · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco (H.S.R.) · Aichi Cancer Center, Nagoya (H.I.), Kanagawa Cancer Center, Yokohama (T.Y.), Saitama Cancer Center, Saitama (K.I.), and National Hospital Organization Hokkaido Cancer Center, Sapporo (M.T.) - all in Japan · Istituto Oncologico Veneto and the Departments of Surgery, Oncology, and Gastroenterology, University of Padua, Padua, Italy (P.C.) · Vanderbilt University, Nashville (I.A.M.) · Chaim Sheba Medical Center, Tel Hashomer, Israel (B.K.) · National Taiwan University Hospital, Taipei (Y.-S.L.) · Novartis Pharma, Basel, Switzerland (D.M., C.W.) · Novartis Pharmaceuticals, East Hanover, NJ (S.H.) · and Massachusetts General Hospital Cancer Center, Boston (D.J.). · Pubmed 31091374
  • The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX 77030, USA. · Dana-Farber Cancer Institute, Center for Women's Cancers, Boston, MA 02215, USA. · Memorial Sloan-Kettering Cancer Center, Bobst International Center, New York, NY 10065, USA. · University of North Carolina School of Medicine, Duke Cancer Center, Chapel Hill, NC 27710, USA. · University of California San Francisco, Department of Medicine (Hematology/Oncology), San Francisco, CA 94115, USA. · University of Leeds, Leeds Institute of Cancer and Pathology (LICAP), Leeds, LS2 9JT, UK. · St James' University Hospital, Institute of Oncology, Leeds, LS9 7BE, UK. · Institut Curie, Oncological Medicine Department, 75248, Paris, France. · University Medical Center Hamburg-Eppendorf, Department of Obstetrics and Gynecology, 20246 Hamburg, Germany. · Nektar Therapeutics, San Francisco, CA 94158, USA. · IOB Institute of Oncology, Quironsalud Group, 28034 Madrid & 08023 Barcelona, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Breast Cancer and Melanoma Group, 08035 Barcelona, Spain. · Pubmed 31074641
  • Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, 450 Brookline Avenue, Boston, MA, USA. · Department of Statistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Breast Cancer Medicine Service, Solid Tumor Division, Department of Medicine, Memorial Sloan Kettering Cancer Center and Department of Medicine, Weill Cornell Medical Center, New York, NY, USA. · Department of Medical Oncology, Sarah Cannon Cancer Center, Nashville, TN, USA. · Department of Hematology-Oncology, Massachusetts General Hospital, Boston, MA, USA. · Division of Medical Oncology, Department of Medicine, Duke Cancer Institute, Durham, NC, USA. · Division of Hematology/Oncology, Department of Medicine, Cardinal Bernardin Cancer Center, Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA. · Department of Medicine, Division of Oncology, Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Department of Medical Oncology, Baylor Clinic-Lester and Sue Smith Breast Center, Houston, TX, USA. · Department of Oncology, Johns Hopkins Kimmel Cancer Center, Baltimore, MD, USA. · Department of Medical Oncology, UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · American Society of Clinical Oncology, Alexandria, VA, USA. · Pubmed 31004299
  • From the Massachusetts General Hospital Cancer Center (A.B., S.J.I.) and Dana-Farber Cancer Institute (S.M.T.), Harvard Medical School, Boston · Vanderbilt-Ingram Cancer Center, Nashville (I.A.M., V.G.A.) · Weill Cornell Medical College (L.T.V.) and New York-Presbyterian-Columbia University Irving Medical Center (K.K.), New York · University of Colorado Cancer Center, Aurora (J.R.D.) · Texas Oncology, Baylor University Medical Center, US Oncology, Dallas (J.O.) · Orlando Health University of Florida Health Cancer Center, Orlando (R.L.M., N.C.S.) · Yale University School of Medicine, New Haven, CT (A.D.S.) · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco (H.S.R.) · Immunomedics, Morris Plains, NJ (D.M.G., R.I., S.W., R.M.S., W.A.W.) · and AIS Consulting, Ann Arbor, MI (A.M.S.). · Pubmed 30786188
  • Department of Medicine (Hematology/Oncology), University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St, 2nd Floor, San Francisco, CA, 94115, USA. · Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Santa Monica, CA, USA. · Department of Medical Oncology, Institut Curie, Paris, France. · Centre Eugène Marquis, Rennes, France. · Frauenklinik und Poliklinik Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Republican Clinical Oncology Dispensary, State Budget Medical Institution, Ufa, Russia. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada. · Department of Obstetrics and Gynecology, Brustzentrum der Universität München (LMU), Munich, Germany. · Breast Cancer Center, Memorial Cancer Institute, Hollywood, FL, USA. · Patient and Health Impact, Pfizer Inc, New York, NY, USA. · Clinical Statistics, Pfizer Inc, La Jolla, CA, USA. · Global Product Development, Clinical, Pfizer S.r.l, Milan, Italy. · Global Product Development, Clinical, Pfizer Inc, San Francisco, CA, USA. · Global Product Development, Clinical, Pfizer Inc, Collegeville, PA, USA. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada. · Pubmed 30632023
  • Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston. · Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston. · at the time of the study, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Oncology, Sarah Cannon Research Institute, Tennessee Oncology Professional Limited Liability Corporation, Nashville. · Department of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, German Cancer Consortium, Germany. · Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany. · Department of Hematology/Oncology, SozialStiftung Bamberg, Bamberg, Germany. · Department of Medical Oncology, Catalan Institute of Oncology-Bellvitge Biomedical Research Institute, Barcelona, Spain. · Department of Oncology, Churchill Hospital Cancer Centre, Oxford, United Kingdom. · At the time of the study, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Cellex Center, Barcelona, Spain. · Translational Clinical Oncology, Novartis Pharma AG, Basel, Switzerland. · At the time of the study, Novartis Oncology Translational Research, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts. · Tango Therapeutics, Cambridge, Massachusetts. · Department of Medicine, University of California at San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco. · Pubmed 30543347
  • Department of Biostatistics and Epidemiology, University of California San Francisco, San Francisco, California, USA. · Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA. · Alliance Statistics and Data Center, Duke University, Durham, North Carolina, USA. · Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan. · Department of Medicine, Northwestern University, Chicago, Illinois, USA. · Department of Medicine, University of California San Francisco, San Francisco, California, USA. · DeBartolo Family Personalized Medicine Institute, Moffitt Cancer Center, Tampa, Florida, USA. · Department of Medicine, The University of Chicago, Chicago, Illinois, USA. · Nash General Hospital, Rocky, North Carolina, USA. · Washington University School of Medicine, St. Louis, Missouri, USA. · Dana-Farber/Partners Cancer Care, Boston, Massachusetts, USA. · Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA. · Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA. · Pubmed 30260474
  • Department of Medicine (Hematology/Oncology), University of California San Francisco, Comprehensive Cancer Center, San Francisco, CA. Electronic address: · Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Santa Monica, CA. · Department of Medical Oncology, British Columbia Cancer, Vancouver, BC, Canada. · Division of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada. · Department of OB&GYN, Brustzentrum, Frauenklinik der Universität München (LMU), Munich, Germany. · Memorial Healthcare System, Breast Cancer Center, Pembroke Pines, FL. · Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan. · Department of Medical Oncology, St Vincent's University Hospital and Cancer Trials Ireland, Dublin, Ireland. · Global Product Development, Clinical, Pfizer S.r.l., Milan, Italy. · Global Product Development, Clinical, Pfizer Inc, San Francisco, CA. · Pfizer Inc, Clinical Statistics, La Jolla, CA. · Pfizer Oncology, US Medical Affairs, New York, NY. · Hospital Gregorio Maranon, Universidad Complutense, Madrid, Spain. · Oncologie sénologique, Centre Eugene Marquis, Rennes, France, and Institut Curie, Paris, France. · Pubmed 31836434
  • The University of Chicago, Chicago, Illinois, USA. · Center for Translational Medicine, University of Maryland, Baltimore, Maryland, USA. · Alliance Statistics and Data Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Dana-Farber/Partners CancerCare/Harvard Cancer Center, Boston, Massachusetts, USA. · Heartland Cancer Research NCORP, St. Louis, Missouri, USA. · Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA. · Mayo Clinic, Jacksonville, Florida, USA. · John H. Stroger Jr Hospital of Cook County, Chicago, Illinois, USA. · Decatur Memorial Hospital/Cancer Care Specialists of Illinois/Heartland Cancer Research NCORP, Decatur, Illinois, USA. · University of California San Francisco, San Francisco, California, USA. · Pubmed 31802506
  • University of California, Los Angeles, Los Angeles, California, USA · Institut Paoli-Calmettes, Marseille, France. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Seoul National University Hospital, Seoul, South Korea. · Kaiser Permanente, Northern California, Vallejo, California, USA. · MD Anderson Cancer Center, Gilbert, Arizona, USA. · Rocky Mountain Cancer Centers, Littleton, Colorado, USA. · Baylor Sammons Cancer Center Texas Oncology, U.S. Oncology, Dallas, Texas, USA. · Pfizer Ltd, Surrey, United Kingdom. · Pfizer, Inc., La Jolla, California, USA. · Pfizer Inc., Collegeville, Pennsylvania, USA. · Pfizer Inc., San Francisco, California, USA. · Pfizer Inc., Cambridge, Massachusetts, USA. · The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Obstetrics and Gynecology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Pubmed 31767793
  • Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA. · Philip R. Lee Institute for Health Policy Studies, Center for Healthcare Value, University of California, San Francisco, CA, USA. · Department of Medicine, Epidemiology & Biostatistics, San Francisco, CA, USA. · Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Sutter Medical Foundation, Sacramento, CA, USA. · Pubmed 31736191
  • Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA · Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. · Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA. · Florida Precision Oncology, a division of 21st Century Oncology, Boca Raton, Florida, USA. · Breast Oncology, Division of Hematology/Oncology, University of Vermont Cancer Center, University of Vermont Medical Center, Burlington, Vermont, USA. · Inflammatory Breast Cancer Research Foundation, West Lafayette, Indiana, USA. · Department of Medical Oncology, Baylor University Medical Center, Texas Oncology and U.S. Oncology, Dallas, Texas, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA. · Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C., USA. · Sarah Cannon Research Institute and Tennessee Oncology, Nashville, Tennessee, USA. · Personalized Healthcare, Product Development, Genentech, Inc., South San Francisco, California, USA. · U.S. Medical Affairs, F. Hoffmann-La Roche, Mississauga, Ontario, Canada. · U.S. Medical Affairs, Genentech, Inc., South San Francisco, California, USA. · David Geffen School of Medicine, University of California Los Angeles, Los Angeles California, USA. · Pubmed 31611330
  • Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. Electronic address: · McGill University Health Centre, Montreal, QC, Canada. · German Breast Group, Neu-Isenburg, Germany. · University of Ulm, Ulm, Germany. · Texas Oncology-Baylor Sammons Cancer Center/U.S. Oncology, Dallas, TX, USA. · University of California San Francisco, San Francisco, CA, USA. · NSABP Foundation and Allegheny General Hospital, Pittsburgh, PA, USA. · AbbVie, North Chicago, IL, USA. · Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · Women and Infants Hospital of Rhode Island, Providence, RI, USA. · Helios Klinikum Berlin-Buch, Berlin, Germany. · Pubmed 31606288
  • BC Cancer, Vancouver, BC, Canada. · Feinberg School of Medicine, Robert H. Lurie Cancer Center of Northwestern University, Chicago, IL, USA. · Diller Family Comprehensive Cancer Center, University of California San Francisco Helen, San Francisco, CA, USA. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada. · Breast Cancer Center, Memorial Healthcare System, Hollywood, FL, USA. · Mercy Hospital St. Louis, St. Louis, MO, USA. · Pfizer Oncology, Milan, Italy. · Pfizer Oncology, Cambridge, MA, USA. · Pfizer Inc, La Jolla, CA, USA. · Pfizer Oncology, New York, NY, USA. · David Geffen School of Medicine, University of California Los Angeles, Santa Monica, CA, USA. · Pubmed 31448513
  • Susan F. Smith Center for Women's Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Division of Hematology and Oncology, University of Pennsylvania Abramson Cancer Center, Philadelphia. · Division of Hematology and Medical Oncology, University of California San Francisco Helen Diller Comprehensive Cancer Center, San Francisco. · Division of Hematology/Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis. · Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston. · Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center, Boston. · Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston. · Pfizer, Inc., New York, USA. · Pubmed 31250880
  • Department of Medical Oncology, Centre Eugène Marquis, Rennes, France · Brustzentrum der Universität München, Munich, Germany. · Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. · British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Frauenklinik und Poliklinik Klinikum rechts der Isar, Technische Universität, München, Munich, Germany. · University of Calgary, Calgary, Alberta, Canada. · Pfizer Inc., La Jolla, California, USA. · Pfizer Inc., San Francisco, California, USA. · Pfizer Inc., New York New York, USA. · Pfizer s.r.l., Milan, Italy. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · David Geffen School of Medicine at UCLA, Santa Monica, California, USA. · Pubmed 31217344
  • Department of Medicine, Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA, USA. · Wellstar Atlanta Medical Center, Atlanta, GA, USA. · Emeritus Professor, Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA. · Department of Medicine, Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA, USA. · Pubmed 31172405
  • Department of Medicine, Perlmutter Cancer Center, New York University School of Medicine, New York, USA. · Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University London, London, UK. · Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco. · Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Institut Curie, Paris, France. · Oncology Medicine Department, Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Aichi Cancer Center Hospital, Nagoya, Japan. · Institut de Cancerologie de l'Ouest, Nantes, France. · Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, USA. · Westmead Hospital and the University of Sydney, Sydney, Australia. · Department of Oncology and Hematology, University of Milano, Milan. · IEO, European Institute of Oncology IRCCS, Milano, Milan, Italy. · Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, USA. · Baylor University Medical Center, Dallas. · Texas Oncology, Dallas. · US Oncology, Dallas, USA. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · Breast Cancer Service for Young Women, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel. · Levine Cancer Institute, Atrium Health, Charlotte. · Merck & Co., Inc., Kenilworth, USA. · Breast Cancer Program, Vall d'Hebron Institute of Oncology, Barcelona. · Ramon y Cajal University Hospital, Madrid. · IOB Institute of Oncology, Quiron Group, Barcelona, Spain. · Pubmed 30475950
  • Department of Medicine, Perlmutter Cancer Center, New York University School of Medicine, New York, USA. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, USA. · Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Dipartimento di Senologia, Istituto Nazionale Tumori - "Fondazione Pascale," Naples, Italy. · Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago. · Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa. · Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. · Breast Disease Research Group, The Christie NHS Foundation Trust, Manchester, UK. · Department of Oncology, Mayo Clinic, Rochester, USA. · Aichi Cancer Center Hospital, Nagoya, Japan. · Division of Oncology, Sourasky Medical Center (Ichilov), Tel Aviv, Israel. · Department of Gynecology and Obstetrics, University Carl Gustav Carus, TU Dresden, Dresden, Germany. · Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco. · Levine Cancer Institute, Atrium Health, Charlotte. · Merck & Co., Inc., Kenilworth, USA. · Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University London, London, UK. · Pubmed 30475947
  • 1Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA USA. · 0000 0001 2297 6811 · grid.266102.1 · 2Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA USA. · 3Department of Pathology, University of California San Francisco, San Francisco, CA USA. · Pubmed 31240240
2018
  • European School of Oncology (ESO), European Society for Medical Oncology (ESMO) and Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. · European Society for Medical Oncology (ESMO) and Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · European School of Oncology, Milan, Italy. · Europa Donna Cyprus, Nicosia, Cyprus. · Oncology Department, Clinique de Genolier, Genolier, Switzerland. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Breast Centre, Department of Obstetrics and Gynaecology, University of Munich (LMU), Munich, Germany. · Direction Office, ULACCAM (Union Latinoamericana Contra el Cáncer de la Mujer), Mexico DF, Mexico. · Department of Oncology, PURCS School of Medicine, Porto Alegre, Brazil. · Department of Oncology-Pathology, Karolinska Institute & University Hospital, Stockholm, Sweden. · European Society of Breast Cancer Specialists (EUSOMA) and Department of Medical Oncology, Nuovo Ospedale di Prato - Istituto Toscano Tumori, Prato, Italy. · CB Boers Organization, Wormer, The Netherlands. · Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation and Nova Medical School, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, USA. · Department of Oncology, Vall d' Hebron University, Barcelona, Spain. · Division of Early Drug Development, Department of Oncology and Hemato-Oncology, European Institute of Oncology, University of Milano, Milano, Italy. · Gynaecology and Breast Department, Centre Eugène Marquis, Rennes, France. · Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Breast Cancer Department, Cancer Institute Ion Chiricuta, Cluj-Napoca, Romania. · SHORE-C, Brighton & Sussex Medical School, University of Sussex, Brighton, UK. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · Medical Oncology Department, BC Cancer Agency, Vancouver, Canada. · Department of Medicine, The Royal Marsden, Sutton, UK. · Department of Oncology, Sheba Medical Center, Ramat Gan, Israel. · Department of Medical Oncology, Bombay Hospital Institute of Medical Sciences, Mumbai, India. · Breast Oncology Center Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Advocacy Department, UWOCASO (Uganda Women's Cancer Support Organization), Kampala, Uganda. · European Society of Radiation Oncology (ESTRO) and Department of Experimental Clinical Oncology & Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. · Cancer Institute Hospital, Breast Oncology Centre, Tokyo, Japan. · Institute of Oncology of Southern Switzerland, Geneva University Hospitals, Swiss Group for Clinical Cancer Research (SAKK), International Breast Cancer Study Group (IBCSG), Bellinzona, Switzerland. · Oncology Institute, Shaare Zedek Medical Centre, Jerusalem, Israel. · Department of Pathology, Centre Jean Perrin, Clermont-Ferrand Cedex, France. · IDIBAPS (Institut d'Investigacions Biomèdiques August Pi iSunyer), Hospital Clínic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumor, Barcelona, Spain. · Breast Oncology Clinical Trials Education, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Oncology Division, Stanford University Medical Center, Stanford, USA. · Policy Department, Breast Cancer Network Australia, Camberwell, VIC, Australia. · Department of Gynaecology, Martin Luther University Halle-Wittenburg, Halle, Germany. · Oncology Department, Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York. · Dana-Farber Cancer Institute, Susan Smith Center for Women's Cancers, Breast Oncology Center, Boston, USA. · Pubmed 30032243
  • University of California San Francisco Comprehensive Cancer Center, USA. Electronic address: · Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology, Barcelona, Spain; IOB Institute of Oncology, Quiron Group, Madrid & Barcelona, Spain. · Pubmed 29680363
  • Cleveland Clinic, Cleveland, USA. · Hematology Oncology Associates, Lake Worth, FL, USA. · University of Sheffield, Sheffield, UK. · University of Colorado, Denver, CO, USA. · Mayo Clinic, Rochester, USA. · Loyola University, Maywood, USA. · University of Cincinnati, Cincinnati, USA. · University of Miami, Deerfield Beach, FL, USA. · University of Florida, Orlando, FL, USA. · Stanford University, Stanford, USA. · University of California, San Francisco, USA. · University of Tennessee, Knoxville, USA. · Memorial Sloan Kettering, New York City, USA. · Pubmed 29352368
  • a Division of Hematology and Oncology , Massachusetts General Hospital , Boston , MA , USA. · b Division of Hematology and Oncology , University of California San Francisco, Helen Diller Family Comprehensive Cancer Center , San Francisco , CA , USA. · Pubmed 29192520
  • University of California, Los Angeles, 10945 Le Conte Avenue PVUB 3360, Los Angeles, CA, 90095, USA. Electronic address: · Pfizer Inc., 525 Market Street, 36th Floor, San Francisco, CA, 94105, USA. Electronic address: · The Royal Marsden Hospital-The Royal Marsden NHS Foundation Trust, Fulham Road, Chelsea, London, SW3 6JJ, UK. Electronic address: · Stanford University School of Medicine, 900 Blake Wilbur Drive, 1st Floor, Palo Alto, CA, 94304, USA. Electronic address: · University of California San Francisco Comprehensive Cancer Center, 1600 Divisadero Street, 3rd Floor, San Francisco, CA, 94115, USA. Electronic address: · Centre Oscar Lambret, 3 Rue Frédéric Combemale, 59000, Lille, France. Electronic address: · Klinikum Rechts der Isar, Technische Universität München, Ismaningerstrasse 22, 81675, Munich, Germany. Electronic address: · Universitäts-Frauenklinik Calwerstr. 7, 72076, Tübingen, Germany; Eberhard Karls University, Geschwister-Scholl-Platz, 72074, Tübingen, Germany. Electronic address: · Banner MD Anderson Cancer Center, 2946 E Banner Gateway Dr, Gilbert, AZ, 85234, USA. Electronic address: · Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology, CELLEX CENTER, C/ Natzaret, 115-117, 08035, Barcelona, Spain. Electronic address: · University Hospital Erlangen, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Universitätsstraße 21-23, 91054 Erlangen Erlangen, Germany. Electronic address: · Pfizer Inc., 525 Market Street, 36th Floor, San Francisco, CA, 94105, USA. Electronic address: · Pfizer Inc., 525 Market Street, 36th Floor, San Francisco, CA, 94105, USA. Electronic address: · Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA. Electronic address: · The NIHR Manchester Clinical Research Facility at The Christie & Division of Cancer Sciences University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. Electronic address: · Pubmed 30359909
  • From the Barts Cancer Institute, Queen Mary University of London, London (P.S.) · Perlmutter Cancer Center, New York University School of Medicine, New York (S.A.) · the Department of Medicine, University of California, San Francisco, San Francisco (H.S.R.), and Genentech, South San Francisco (L.M., S.Y.C., R.F.) - both in California · University Hospital Heidelberg, Heidelberg, Germany (A.S.) · Centro de Pesquisa em Oncologia, Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre (C.H.B.), and the University of São Paulo, São Paulo (R.H.) - both in Brazil · Aichi Cancer Center Hospital, Nagoya, Japan (H.I.) · the Department of Medical Oncology, Institut Curie, Paris (V.D.) · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.) · Florida Cancer Specialists and Research Institute, New Port Richey (G.S.W.) · Roche, Basel, Switzerland (V.H., A.H.) · Dana-Farber Cancer Institute, Boston (E.P.W.) · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S.L.) · and the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore (L.A.E.). · Pubmed 30345906
  • Department of Medicine (Hematology/Oncology), University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. Electronic address: · Department of Medical Oncology, Institut Claudius Regaud, Toulouse, France. · Department of Oncology and Hematology, Kaiser Permanente, Oakland, CA. · Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea. · Division of Oncology, Hospital of Oncologia Maria Curie, Cuidad de Buenos Aires, Argentina. · R-Pharm JSC, Moscow, Russian Federation. · R-Pharm US, Princeton, NJ. · Breast Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 30153978
  • Department of Obstetrics and Gynecology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Pfizer Inc., San Francisco, USA. · Seoul National University Hospital, Seoul, Korea. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · University of California, Los Angeles, USA. · Institut Paoli-Calmettes, Marseille, France. · Kaiser Permanente, Northern California, Vallejo, USA. · Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel. · Banner Health, Phoenix, USA. · Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, GEICAM, Universidad Complutense, Madrid, Spain. · Institut Universitaire du Cancer Toulouse, Toulouse, France. · Samsung Medical Center, Seoul, Korea. · Pfizer Inc., New York, USA. · Interdisziplinäres Onkologisches Zentrum München, Munich, Germany. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas. · MD Anderson Cancer Center, Houston, USA. · Pubmed 30124753
  • Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Washington University School of Medicine, St Louis, MO, USA. · Oncology & Hematology Associates of Southwest Virginia, Inc, Salem, VA, USA. · Sarah Cannon Research Institute and Tennessee Oncology PLLC, Nashville, TN, USA. · Florida Cancer Specialists, St. Petersburg, FL, USA. · Columbia University Medical Center, New York, NY, USA. · Northside Hospital, Inc, Atlanta, GA, USA. · Rocky Mountain Cancer Centers, Aurora, CO, USA. · Incyte Corporation, Wilmington, DE, USA. · University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. · Pubmed 29675680
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Department of Medical Oncology, Institut Claudius Regaud, Oncolpole-Toulouse, France. · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Division of Medical Oncology, UHN Princess Margaret Cancer Centre, Toronto, ON, Canada. · Breast and GYN Early Trials Program, Scottsdale Healthcare Shea Medical Center, Scottsdale, Arizona. · Department of Drug Development and Innovation, Institut Curie, Paris & Saint-Cloud, France, INSERM U900 Research Unit, Saint-Cloud France, and Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France. · Department of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Drug Development Department, Gustave Roussy, Villejuif, France. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Department of Clinical Oncology, Merck & Co., Inc., Kenilworth, New Jersey. · Division of Medical Oncology, Department of Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey. · Pubmed 29559561
  • German Breast Group, Neu-Isenburg, Germany; Centre for Haematology and Oncology Bethanien, Frankfurt, Germany. Electronic address: · Baylor University Medical Center, Dallas, TX, USA. · HELIOS Klinikum Berlin-Buch, Berlin, Germany. · Women & Infants Hospital of Rhode Island, Providence, RI, USA. · University of California San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · AbbVie Inc, North Chicago, IL, USA. · Ulm University, Ulm, Germany. · Brigham and Women's Hospital, Boston, MA, USA. · German Breast Group, Neu-Isenburg, Germany. · National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA. · Texas Oncology, US Oncology, Dallas, TX, USA. · Alicante University General Hospital, ISABIAL, GEICAM (Spanish Breast Cancer Research Group), Alicante, Spain. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA; Magee-Womens Hospital, Pittsburgh, PA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA; Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · Pubmed 29501363
  • Dejan Juric, Massachusetts General Hospital Cancer Center, Boston · Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA · Jordi Rodon and Josep Tabernero, Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona · Marta Gil-Martin, Catalan Institute of Oncology - Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain · Filip Janku, The University of Texas MD Anderson Cancer Center, Houston, TX · Howard A. Burris, Sarah Cannon Research Institute and Tennessee Oncology · Jordan Berlin, Vanderbilt-Ingram Cancer Center, Nashville, TN · Jan H.M. Schellens, Netherlands Cancer Institute, Amsterdam, the Netherlands · Mark R. Middleton, National Institute for Health Research, Oxford Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom · Martin Schuler, West German Cancer Center, University Duisburg-Essen, and German Cancer Consortium, Partner Site University Hospital Essen, Essen · Ruth Seggewiss-Bernhardt, Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany · Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA · Douglas Bootle, David Demanse, Lars Blumenstein, and Cornelia Quadt, Novartis Pharma AG, Basel, Switzerland · Christina Coughlin, Novartis Pharmaceuticals Corporation, East Hanover, NJ · and José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 29401002
  • Department of Medicine (Hematology/Oncology), University of California San Francisco Comprehensive Cancer Center, San Francisco, USA. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, British Columbia Cancer Agency-Vancouver Centre, Vancouver, Canada. · Division of Hematology/Oncology, University of California, Los Angeles, USA. · Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón, GEICAM, Universidad Complutense, Madrid, Spain. · Department of Oncology, Universitair Ziekenhuis Leuven-Campus Gasthuisberg, Leuven, Belgium. · Department of Chemotherapy, Lviv State Oncologic Regional Treatment and Diagnostic Center, Lviv, Ukraine. · Global Product Development, Clinical, Pfizer s.r.l., Milan, Italy. · Global Product Development, Statistics, Pfizer Inc., La Jolla, USA. · Biostatistics, Pfizer Inc., New York, USA. · Medical Affairs, Pfizer Inc., New York, USA. · Global Outcomes and Evidence, Pfizer Inc., New York, USA. · Department of Medical Oncology, The Royal Marsden NHS Foundation, London, UK. · Department of Obstetrics and Gynecology, Frauenklinik und Poliklinik Klinikum Rechts der Isar, Technische Universität München, München, Germany. · Department of Obstetrics and Gynecology, Brustzentrum der Universität München (LMU), München, Germany. · Pubmed 29360932
  • Global Product Development, Pfizer Inc., San Diego. · Pfizer Inc. · Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, California, USA. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. · Department of Obstetrics and Gynecology, Right of the Isar Hospital, Technical University of Munich, Munich, Germany. · Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco. · Pubmed 29360661
  • Division of General Internal Medicine, Department of Medicine, University of California, 1545 Divisadero St, #313, San Francisco, CA, 94143-032, USA. · The ABC Clinic, University of California, San Francisco, CA, USA. · Princeton University, Princeton, NJ, 08544, USA. · Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, CA, USA. · Institute for Health Policy Studies, University of California, San Francisco, CA, USA. · Departments of Surgery and Radiology, University of California, San Francisco, CA, USA. · Pubmed 29086230
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St, San Francisco, CA, 94115, USA. · Department of Psychology, University of Arizona, 1503 E University Blvd, Tucson, AZ, 85721, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St, San Francisco, CA, 94115, USA. · Pubmed 28921303
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital and Institute 52 Fucheng Rd, Beijing 100142, China. · Geneplus-Beijing Beijing 102206, China. · University of Chicago, Division of The Social Sciences 1130E, 59th Street, Chicago 60637, IL, USA. · Department of Medicine, University of California at San Francisco, Helen Diller Family Comprehensive Cancer Center San Francisco, USA. · Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Branch of Medical Statistics, Peking University Cancer Hospital and Institute 52 Fucheng Rd, Beijing 100142, China. · Pubmed 30323979
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, 1600 Divisidero St, San Francisco, CA 94115, USA. Electronic address: · Institute of Cancer Research and Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK. Electronic address: · David Geffen School of Medicine at UCLA, 2825 Santa Monica Blvd, Suite 200, Santa Monica, CA 90404, USA. Electronic address: · Cross Cancer Institute, 11560 University Avenue NW, Edmonton, AB T6G1Z2, Canada. Electronic address: · University of Calgary, 1403-29 St. N.W., Calgary, AB, Canada. Electronic address: · Breast Center, University of Munich (LMU), Marchioninistrasse 15, Munich 81377, Germany. Electronic address: · National Hospital Organization Osaka National Hospital, 2 Chome-1-14 Hoenzaka, Chuo, Osaka, Osaka Prefecture 540-0006, Japan. Electronic address: · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongro-gu, Seoul 03080, South Korea. Electronic address: · Pfizer Inc, 10646 Science Center Dr, San Diego, CA 92121, USA. Electronic address: · Pfizer Inc, 10646 Science Center Dr, San Diego, CA 92121, USA. Electronic address: · Pfizer Inc, 10646 Science Center Dr, San Diego, CA 92121, USA. Electronic address: · Pfizer Inc, 235 E 42nd St, New York, NY 10017, USA. Electronic address: · Pfizer Inc, 235 E 42nd St, New York, NY 10017, USA. Electronic address: · Pfizer Inc, 500 Arcola Rd, Collegeville, PA 19426, USA. Electronic address: · Institute of Cancer Research and Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK. Electronic address: · Pubmed 30053671
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco 94115, USA. · CAS Key Laboratory of Standardization and Measurement for Nanotechnology, the National Center for Nanoscience and Technology of China, Beijing 100190, China. · Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Clinical Laboratory, Peking University Cancer Hospital & Institute, Beijing 100142, China. · Pubmed 30046226
  • Department of Radiation Oncology, University of Michigan Cancer Center, Ann Arbor. · University of California, San Francisco, Comprehensive Cancer Center, San Francisco. · Pubmed 29800965
  • University of California, San Francisco, San Francisco, California. · Ramon y Cajal University Hospital, Madrid, and Vall D'Hebron Institute of Oncology, Barcelona, Spain. · Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, Texas. · University of Leeds and Leeds Teaching Hospital Trust, Leeds, United Kingdom. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. · Nektar Therapeutics, San Francisco, California. · Consultant, San Francisco, California. · ApoCell, Houston, Texas. · Nektar Therapeutics, San Francisco, California. · Mayo Clinic, Jacksonville, Florida. · Pubmed 29618616
  • Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive SRB-2, Tampa, FL 33612, USA. · Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive SRB-2, Tampa, FL 33612, USA; Cancer Biology PhD Program, University of South Florida, Tampa, FL 33620, USA. · Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive SRB-2, Tampa, FL 33612, USA; Department of Breast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA. · Department of Medicine and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA. · Department of Pathology, University of California, San Francisco, CA 94143, USA. · Department of Cell, Developmental & Cancer Biology, and Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA. · Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive SRB-2, Tampa, FL 33612, USA; Department of Breast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA. Electronic address: · Pubmed 29316433
  • Division of Hematology/Oncology, University of California at San Francisco, San Francisco, California. · Division of Hematology/Oncology, University of California at San Francisco, San Francisco, California. · Department of Laboratory Medicine, University of California at San Francisco, San Francisco, California. · Helen Diller Family Comprehensive Cancer Center and Computational Biology and Informatics, University of California at San Francisco, San Francisco, California. · Alliance Statistics and Data Center, Duke University, Durham, North Carolina. · Alliance Statistics and Data Center, Dana-Farber Cancer Institute, Boston, Massachusetts. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 29311117
  • Department of Medicine (Hematology/Oncology), Director Breast Oncology Clinical Trials Program, University of California San Francisco, San Francisco, CA. · Medical Device Consultants of Ridgewood LLC, Ridgewood, NJ. Electronic address: · Pubmed 28939291
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA. · Indiana University Medical CTR, Indianapolis, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Pubmed 27927580
  • Amy Jo Chien and Hope S. Rugo, University of California San Francisco Comprehensive Cancer Center, San Francisco, CA. · Pubmed 28783451
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University, Cancer Hospital & Institute, Beijing, 100142, China. · Pubmed 29282695
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, UCSF Medical Center at Mount Zion, 1600 Divisadero St, San Francisco, CA, 94115, USA. · Wake Forest University Baptist Medical Center, Medical Center Blvd, Fl 3, Winston Salem, NC, 27157, USA. · Medical Device Consultants Ridgewood, LLC, 99 Glenwood Rd, Ridgewood, NJ, 07450, USA. · Pubmed 28275922
  • UCSF Helen, Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA, 94115, USA. · Centre Léon Bérard, Lyon, France. · National Cancer Center, Goyang, Republic of Korea. · H. de Lleida Arnau de Vilanova, Lerida, Spain. · Institut de Cancérologie de l'Ouest, St Herblain-Nantes, France. · University Hospital of Parma, Parma, Italy. · Instituto Português de Oncologia Francisco Gentil, Porto, Portugal. · Korea University Medical Center, Seoul, Republic of Korea. · Ramón y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Merck& Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · Alexion Pharmaceuticals, New Haven, CT, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28681171
  • Center for Translational Medicine, School of Pharmacy, University of Maryland, Baltimore, Maryland, USA. · University of Chicago, Chicago, Illinois, USA. · NorthShore University Health System, Evanston, Illinois, USA. · State Key Laboratory of Natural and Biomimetic Drugs (Peking University), Beijing, China. · Alliance Statistics and Data Center, Duke University, Durham, North Carolina, USA. · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Dana-Farber/Partners CancerCare/ Harvard Cancer Center, Boston, Massachusetts, USA. · Heartland Cancer Research NCORP, St. Louis, Missouri, USA. · Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA. · Mayo Clinic, Rochester, Minnesota, USA. · John H. Stroger Jr Hospital of Cook County, Chicago, Illinois, USA. · Decatur Memorial Hospital/Cancer Care Specialists of Illinois/ Heartland Cancer Research NCORP, Decatur, Illinois, USA. · University of California-San Francisco, San Francisco, California, USA. · Center for Translational Medicine, School of Pharmacy, University of Maryland, Baltimore, Maryland, USA. · Center for Translational Medicine, School of Pharmacy, University of Maryland, 20 N Pine Street, Room 513, Baltimore, Maryland, 21201, USA. · Pubmed 28620884
  • Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. · University of California, San Francisco, 1600 Divisadero St., San Francisco, CA, 94115, USA. · Valley Medical Oncology Consultants, Stanford Health Care, 2505 Hospital Drive, Mountain View, CA, 94040, USA. · University of California, San Francisco, 1600 Divisadero St., San Francisco, CA, 94115, USA. · Pubmed 28577080
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Boston, Massachusetts. · University of California San Francisco Comprehensive Cancer Center, San Francisco, California. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Ramón y Cajal University Hospital, Madrid, Spain. · Institut Curie, Paris, France. · Texas Oncology, Austin, Texas. · Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, Texas. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center, New York, New York. · Sarah Cannon Research Institute, Tennessee Oncology PLLC, Nashville, Tennessee. · Eli Lilly and Company, Indianapolis, Indiana. · Pubmed 28533223
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St., Box 1710, San Francisco, CA, 94115, USA. · University of California San Francisco School of Medicine, Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St., Box 1710, San Francisco, CA, 94115, USA. · Columbia University College of Physicians and Surgeons, New York, NY, USA. · Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, CA, USA. · Pubmed 28503722
  • Leeds Institute of Cancer and Pathology and St James's Institute of Oncology, Leeds, UK. Electronic address: · Ramon y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Baylor-Sammons Cancer Center, Texas Oncology, U.S. Oncology, Dallas, TX, USA. · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Mayo Clinic, Jacksonville, FL, USA. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota, Department of Medicine, Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Ramon y Cajal University Hospital, Madrid, Spain. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Consultant, Sebastopol, CA, USA. · University of California, San Francisco, CA, USA. · Pubmed 28360015
  • Memorial Sloan Kettering Cancer Center, New York, NY, USA. · H. de Lleida Arnau de Vilanova, Lérida, Spain. · Institut Jules Bordet, Brussels, Belgium. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Institute of Clinical Research, Odense University Hospital, University of Southern Denmark, Odense, Denmark. · Ramon y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Massachusetts General Hospital, Boston, MA, USA. · Mayo Clinic, Rochester, MN, USA. · University of Minnesota Masonic Clinical Cancer Center, Minneapolis, MN, USA. · Hospital 12 de Octubre, Madrid, Spain. · Clinique Sainte Elisabeth, Namur, Belgium. · Merck & Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St., San Francisco, CA, USA. · Pubmed 28324268
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. Electronic address: · Los Angeles Cancer Network, Los Angeles, CA, USA. · Highlands Oncology Group, Fayetteville, AR. · University of California Los Angeles School of Medicine, Los Angeles, CA, USA. · Oncology Consultants PA, Department of Research, Houston, TX, USA. · St Luke's Cancer Institute, Kansas City, MO, USA. · Cancer Treatment Centers of America, Atlanta, GA, USA. · Kaiser Permanente Mid-Atlantic States, Gaithersburg, MD, USA. · UC Irvine Health Chao Family Comprehensive Cancer Center, Orange, CA, USA. · Vanderbilt-Ingram Comprehensive Cancer Center, Nashville, TN, USA. · Oncology and Diagnostic Sciences, Dental School and The Marlene and Stewart Greenebaum Comprehensive Cancer Center University of Maryland Medical Center, Baltimore, MD, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Pubmed 28314691
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco. · Biocon Research Limited, Bangalore, India3Now with Mylan Inc, Canonsburg, Pennsylvania. · Department of Haematology, Oncology, and Stem Cell Transplantation, University Medical Centre Freiburg and Faculty of Medicine, University of Freiburg, Freiburg, Germany. · Quiron-Dexeus, Barcelona, Spain. · Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland. · Mylan Inc, Canonsburg, Pennsylvania. · Biocon Research Limited, Bangalore, India. · City Clinical Oncology Dispensary, Saint Petersburg, Russia. · Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine. · Regional Clinical Oncological Center, Kazan, Russia. · Institute of Clinical Oncology, Tbilisi, Georgia. · St Luke's Medical Center Global City, Taguig City, Philippines. · Cardinal Santos Medical Center, Manila, Philippines. · Golden Fleece 21 Century Health House Ltd, Tbilisi, Georgia. · Siriraj Hospital, Bangkok, Thailand. · Sumy State University, Sumy, Ukraine. · King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand. · City Cancer Center, Vijayawada, India. · Curie Manavata Cancer Centre, Nasik, India. · Instituto Clinico Oncologico del Sur, Temuco, Chile. · Pubmed 27918780
  • Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco. · Samuel Merritt University, Oakland, California. · Pubmed 27832260
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 28949948
  • Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco. · Pubmed 28727874
  • University of California-San Francisco Comprehensive Cancer Center, San Francisco. · Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 28715579
  • Ramon y Cajal University Hospital, Madrid, Spain, and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · University of California, San Francisco, CA, USA. · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Leeds Institute of Cancer and Pathology and St James's University Hospital, Leeds, UK. · Mayo Clinic, Jacksonville, FL, USA. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · , The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · Department of Medicine, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Consultant, Sebastopol, CA, USA. · Texas Oncology-Baylor Charles A. Sammons Cancer Center/U.S. Oncology, 3410 Worth Street, Suite 400, Dallas, TX, 75246, USA. · Pubmed 28612225
  • Executive Vice Chair, Surgery; Associate Director, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA. · Professor of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA. · Vice President, Healthcare Outcomes and Policy, Roswell Park Cancer Institute, Buffalo, NY. · Associate Professor, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Medicine; Director, Breast Oncology and Clinical Trials Education, University of California, San Francisco, San Francisco, CA. · Chairman, Department of Radiation Oncology, Albert Einstein Healthcare Network, Philadelphia, PA. · Professor of Pathology, University of Vermont, Burlington, VT. · Associate Director, Kellogg Cancer Surgical Services, NorthShore University HealthSystem, Evanston, IL. · Professor; Co-Director, Breast Cancer Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 28294295
  • University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, 94115, USA. Electronic address: · Helsinn Healthcare SA, 6912, Pazzallo, Lugano, Switzerland. · IMO Clinique de Genolier, CH-1272, Genolier, Vaud, Switzerland. · Pubmed 28285236
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco. · Icahn School of Medicine at Mount Sinai, New York, New York. · Wake Forest Baptist Health Medical Center, Wake Forest School of Medicine, Winston-Salem, North Carolina. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles. · Weill Cornell Medical College, New York, New York. · Target Health Inc, New York, New York. · Dignitana AB, Lund, Sweden. · Wake Forest School of Medicine, Winston-Salem, North Carolina. · Columbia University, New York, New York10Now with the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. · Pubmed 28196257
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 29200414
2016
  • Hope S. Rugo, University of California San Francisco Comprehensive Cancer Center · Barbara Fowble, University of California San Francisco, San Francisco · Rita S. Mehta, University of California Irvine, Orange, CA · R. Bryan Rumble, American Society of Clinical Oncology, Alexandria · James L. Khatcheressian, Virginia Cancer Institute, Richmond, VA · Erin Macrae, Columbus Oncology and Hematology Associates, Columbus, OH · Debra L. Barton, University of Michigan School of Nursing, Ann Arbor, MI · Hannah Klein Connolly, Patient Representative, Edina, MN · Maura N. Dickler, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY · Lesley Fallowfield, Sussex Health Outcomes Research and Education in Cancer, Brighton and Sussex Medical School, University of Sussex, Sussex · Stephen R.D. Johnston, Royal Marsden Hospital, London, United Kingdom · James N. Ingle, Mayo Clinic, Rochester, MN · Mohammad Jahanzeb, University of Miami Sylvester Comprehensive Cancer Center, Deerfield Beach, FL · Larissa A. Korde, University of Washington, Seattle, WA · Hyman B. Muss, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC · and Harold J. Burstein, Dana-Farber Cancer Center, Boston, MA. · Pubmed 27217461
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD · University of California San Francisco Comprehensive Cancer Center, San Francisco, CA. · Pubmed 27185850
  • School of Dental Medicine and Neag Comprehensive Cancer Center, UConn Health, Farmington, Connecticut. · Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Eastman Institute for Oral Health, University of Rochester Medical Center, Rochester, New York. · Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York. · School of Dentistry, University of Washington and Seattle Cancer Care Alliance, Seattle, Washington. · New York University College of Dentistry, New York, New York. · Penn State Hershey Medical Center, Hershey, Pennsylvania. · Tennessee Oncology/Sarah Cannon Research Institute, Nashville, Tennessee. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California. · School of Dentistry and the Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland. · Pubmed 27334013
  • From the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of San Francisco School of Medicine, San Francisco, CA; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO. · Pubmed 27249746
  • University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. Electronic address: · Pubmed 26507507
  • Division of Hematology-Oncology, University of California, San Francisco, San Francisco, CA. · Division of Hematology-Oncology, University of California, San Francisco, San Francisco, CA. Electronic address: · Pubmed 26303211
  • From the Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at the University of California, Los Angeles, Santa Monica (R.S.F., D.J.S.) · the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco (H.S.R.) · and Pfizer, La Jolla (E.G., D.R.L., S.R.) - all in California · Hospital Gregorio Maranon, Universidad Complutense, Madrid (M.M.) · U.S. Oncology Research, The Woodlands, TX (S.J.) · Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.) · British Columbia Cancer Agency, Vancouver, Canada (K.G.) · Brustzentrum der Universität München (LMU), Munich, Germany (N.H.) · State Budget Medical Institution Republican Clinical Oncology, Ufa, Russia (O.N.L.) · All-Ireland Cooperative Oncology Research Group, Dublin (J.M.W.) · M.D. Anderson Cancer Center, University of Texas, Houston (S.M.) · and Institut Curie, Paris (V.D.). · Pubmed 27959613
  • University of Calgary, Alberta, Canada · Pfizer Inc., Collegeville, Pennsylvania, USA. · Pfizer Inc., New York, New York, USA. · University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · National Cancer Center, Goyang-si, Republic of Korea. · Istituto Europeo di Oncologia, Milan, Italy. · Aichi Cancer Center Hospital, Nagoya, Japan. · Brustzentrum der Universität München, Munich, Germany. · Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois, USA. · Pfizer Inc., San Diego, California, USA. · Pfizer Inc., Cambridge, Massachusetts, USA. · Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Pubmed 27368881
  • Maura N. Dickler, Mary Ellen Moynahan, Diana E. Lake, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY · William T. Barry, Dana-Farber Cancer Institute · Eric P. Winer, Dana-Farber/Partners Cancer Care, Boston, MA · Constance T. Cirrincione, Duke University, Durham, NC · Matthew J. Ellis, Baylor College of Medicine · Debasish Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX · Federico Innocenti and Lisa A. Carey, University of North Carolina at Chapel Hill, Chapel Hill, NC · Arti Hurria, City of Hope, Duarte · Hope S. Rugo, University of California at San Francisco, San Francisco, CA · Olwen Hahn, Alliance for Clinical Trials in Oncology, Chicago, IL · and Bryan P. Schneider, Indiana University School of Medicine, Indianapolis, IN. · Pubmed 27138575
  • Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St, Box 1710, San Francisco, CA, 94115, USA. · Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St, Box 1710, San Francisco, CA, 94115, USA. · Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc, Kenilworth, NJ, USA. · Merck Research Laboratories, North Wales, PA, USA. · Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Laboratory Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, Sanfrancisco, CA, USA. · Pubmed 26875185
  • Department of Cell and Tissue Biology, University of California, San Francisco (UCSF), San Francisco, California, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA. · Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA. · Department of Surgery, University of California, San Francisco, San Francisco, California, USA. · Cancer and Developmental Therapeutics Program, Buck Institute for Research on Aging, Novato, California, USA. · Department of Anatomy, University of California, San Francisco, San Francisco, California, USA. · Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, USA. · Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, USA. · Department of Medicine, University of California, San Francisco, San Francisco, California, USA. · Pubmed 27775705
  • Ramon y Cajal University Hospital, Madrid, Spain ; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron 119-129, Barcelona, Spain. · University of California, San Francisco, CA USA. · St. James's University Hospital, University of Leeds, Leeds, UK. · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Mayo Clinic, Jacksonville, FL USA. · Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. · Nektar Therapeutics, San Francisco, CA USA. · Consultant, Sebastopol, CA USA. · Baylor-Sammons Cancer Center, Texas Oncology, U.S. Oncology, Dallas, TX USA. · Pubmed 27441152
  • Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA. · Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, IL, USA. · Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · Department of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA. · Department of Medical Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Pubmed 27224917
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA. Electronic address: · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA. · Pubmed 26874902
  • Dana-Farber Cancer Institute, Boston, MA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Massachusetts General Hospital, Boston, MA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26868124
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco · The University of Texas MD Anderson Cancer Center, Houston, USA. · Charité Universitätsmedizin Berlin/Campus Virchow-Klinikum, Berlin, Germany. · Hôpital Saint-André, Bordeaux University Hospital, Bordeaux, France. · University of Cincinnati College of Medicine, Cincinnati, USA. · Novartis Pharma AG, Basel, Switzerland. · Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 26759276
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, West Harrison, New York. · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Breast Cancer Research, Sarah Cannon Research Institute, Nashville, Tennessee. · Department of Medicine, Duke University Medical Center, Durham, North Carolina. · Department of Medicine, Cardinal Bernardin Cancer Center, Loyola University Chicago, Chicago, Illinois. · Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco. · Department of Medicine, Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis. · Department of Medicine, Washington University School of Medicine, St Louis, Missouri. · Department of Hematology Oncology, Hofstra North Shore-Long Island Jewish School of Medicine, Hempstead, New York. · Department of Oncology, The Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland. · Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill. · Department of Medicine, Massachusetts General Hospital, Boston. · Department of Medicine, Cardio-Oncology Program, Vanderbilt School of Medicine, Nashville, Tennessee. · Pubmed 26539793
  • Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX · David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ · Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels · Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium · Hope S. Rugo, University of California, San Francisco · Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA · Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada · Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain · Thomas Bachelot, Centre Léon Bérard, Lyon, France · Shinzaburo Noguchi, Osaka University Medical School · Norikazu Masuda, Osaka National Hospital, Osaka, Japan · Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL · Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ · Shaker Dakhil, Cancer Center of Kansas, Wichita, KS · Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA · and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 26503204
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 27379943
2015
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China. · University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St, Box 1710 San Francisco CA 94115, USA. · Pubmed 26557900
  • Mayo Clinic, Jacksonville, FL, USA. Electronic address: · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Baylor-Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · University of California, San Francisco, CA, USA. · University of Leeds and St James's University Hospital, Leeds, UK. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota Department of Medicine and Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Mayo Clinic, Jacksonville, FL, USA. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Sebastopol, CA, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain; Ramon y Cajal University Hospital, Madrid, Spain. · Pubmed 26482278
  • Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA · William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute · Erica L. Mayer and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA · Alvaro Moreno-Aspitia and Edith A. Perez, Mayo Clinic, Jacksonville, FL · Alan P. Lyss, Heartland Cancer Research Community Clinical Oncology Program · Michael Naughton, Washington University School of Medicine, St Louis, MO · Constance Cirrincione and Eleanor Leung, Alliance Statistics and Data Center, Duke University, Durham · Lisa A. Carey, University of North Carolina, Chapel Hill, NC · Deborah Toppmeyer, Cancer Institute of New Jersey, New Brunswick, NJ · and Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26056183
  • Steven J. Isakoff, Lei He, Darrel R. Borger, Dianne M. Finkelstein, Paula D. Ryan, Paul E. Goss, and Leif W. Ellisen, Massachusetts General Hospital Cancer Center · Steven J. Isakoff, Erica L. Mayer, Lei He, Karen Krag, Steven E. Come, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, and Leif W. Ellisen, Harvard Medical School · Erica L. Mayer, Judy E. Garber, and Eric P. Winer, Dana-Farber Cancer Institute · Steven E. Come, Beth Israel Deaconess Medical Center, Boston · Karen Krag, Massachusetts General Hospital/North Shore Cancer Center, Danvers, MA · Tiffany A. Traina, Memorial Sloan Kettering Cancer Center, New York, NY · Lisa A. Carey, The University of North Carolina at Chapel Hill, Chapel Hill, NC · Hope S. Rugo, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA · Minetta C. Liu, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC · Vered Stearns, The Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Kirsten Timms, Myriad Genetics · and Anne-Renee Hartman, Myriad Genetic Laboratories, Salt Lake City, UT. · Pubmed 25847936
  • University of Alabama at Birmingham, Birmingham, Alabama. · HudsonAlpha Institute for Biotechnology, Huntsville, Alabama. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · University of Alabama at Birmingham, Birmingham, Alabama. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Georgetown University Hospital, Washington, District of Columbia. · University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · The University of Chicago, Chicago, Illinois. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana. · Memorial Sloan-Kettering Cancer Center, New York, New York. · University of Michigan, Ann Arbor, Michigan. · Baylor College of Medicine, Houston, Texas. · University of North Carolina, Chapel Hill, North Carolina. · Mayo Clinic College of Medicine, Rochester, Minnesota. · Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, Maryland. · Pubmed 25779953
  • From the Departments of Medical Oncology (S.M.T., B.A.O., A.H.P., I.E.K., H.J.B., E.P.W.) and Biostatistics and Computation Biology (W.T.B., H.G.), Dana-Farber Cancer Institute, and Department of Hematology-Oncology, Massachusetts General Hospital (B.M.) - both in Boston · Breast Cancer Medicine Service, Department of Medicine, Solid Tumor Division, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical Center, New York (C.T.D., C.A.H.), and Department of Medical Oncology, Hofstra North Shore-LIJ School of Medicine, New Hyde Park (I.S.) - all in New York · Sarah Cannon Cancer Center, Department of Medical Oncology, Nashville (D.A.Y.) · Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham (P.K.M.), and Department of Medical Oncology, University of North Carolina, Chapel Hill (L.A.C.) - both in North Carolina · Cardinal Bernardin Cancer Center, Department of Medicine, Division of Hematology-Oncology, Loyola University Chicago Stritch School of Medicine, Maywood, IL (K.S.A.) · Comprehensive Cancer Center, Department of Medicine, Division of Oncology, University of California, San Francisco, San Francisco (H.S.R.) · Department of Medical Oncology, Washington University in St. Louis, St. Louis (M.E.) · and Johns Hopkins Kimmel Cancer Center, Department of Oncology, Baltimore (A.C.W.). · Pubmed 25564897
  • Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Pubmed 26520840
  • Division of Hematology-Oncology, University of California San Francisco, San Francisco, CA, 94115, United States of America. · Siemens Healthcare Diagnostics, Elkhart, IN, 46516, United States of America. · Pubmed 26496203
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Buck Institute for Research on Aging, Novato, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Department of Urology, University of California San Francisco, San Francisco, CA, USA. · UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA. · Pubmed 26021444
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Division of, Medical Oncology, Department of Medicine, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Department of Medical Oncology, Baptist Cancer Center, Memphis, Tennessee. · Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25757412
  • University of Pennsylvania, Philadelphia, Pennsylvania. · University of Minnesota, Minneapolis, Minnesota. · University of Texas MD Anderson Cancer Center, Houston, Texas. · Loyola University Medical Center, Maywood, Illinois. · Buck Institute for Research on Aging, Novato, California. · Mayo Clinic, Rochester, Minnesota. · University of California, San Francisco, San Francisco, California. · British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Oregon Health and Science University, Portland, Oregon. · Inova Fairfax Hospital Cancer Center, Fairfax, Virginia. · University of Colorado Denver, Denver, Colorado. · University of Alabama at Birmingham, Birmingham, Alabama. · University of Texas Southwestern, Dallas, Texas. · Georgetown University Medical Center, Washington, DC. · Swedish Cancer Institute, Seattle, Washington. · University of Washington, Seattle, Washington. · Emory University, Atlanta, Georgia. · H. Lee Moffitt Cancer Center, Tampa, Florida. · University of Chicago, Chicago, Illinois. · QuantumLeap Healthcare Collaborative, San Francisco, California. · University of California, San Diego, San Diego, California. · Gemini Group Ann Arbor, Michigan. · George Mason University, Fairfax County, Virginia. · University of Southern California, Los Angeles, California. · University of Arizona Cancer Center, Tucson, Arizona. · University of California, San Francisco, San Francisco, California. · Pubmed 25712686
  • Antonio C. Wolff, Amanda L. Blackford, Kala Visvanathan, Terry S. Langbaum, and Judith E. Karp, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Hope S. Rugo, University of California, San Francisco Comprehensive Cancer Center, San Francisco, CA · Beverly Moy, Massachusetts General Hospital Cancer Center · Melissa E. Hughes and Jane C. Weeks, Dana-Farber Cancer Institute, Boston, MA · Lori J. Goldstein, Fox Chase Cancer Center, Philadelphia, PA · Keith Stockerl-Goldstein, Siteman Cancer Center at Washington University School of Medicine, St Louis, MO · Leigh Neumayer, Huntsman Cancer Center at University of Utah School of Medicine, Salt Lake City, UT · and Richard L. Theriault, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 25534386
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina. · Baylor University College of Medicine, Houston, Texas. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Duke University Medical Center, Durham, North Carolina. · Georgetown University, Washington, District of Columbia. · Laura & Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, New York. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 25524311
  • Augmentium Pharma Consulting Inc, Toronto, Ontario, Canada. Electronic address: · Sylvester Comprehensive Care Center, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida. · Eisai Inc, Woodcliff Lake, New Jersey. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Pubmed 25433768
  • Division of Hematology-Oncology, University of California San Francisco, San Francisco, California. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 25351747
  • Department of Radiation Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA. Electronic address: · Department of Radiation Medicine and Applied Sciences, University of California San Diego Moores Cancer Center, San Diego, CA. · Athena Breast Health Network, San Francisco, CA. · Department of Medicine (Hematology/Oncology), University of California Helen Diller Comprehensive Cancer Center, San Francisco, CA. · Department of Surgical Oncology, Duke University, Durham, NC. · Department of Surgical Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA. · Department of Radiation Oncology, University of California Irvine, Orange, CA. · Department of Radiation Oncology, Ronald Reagan UCLA Medical Center, UCLA Medical Center, Santa Monica, Santa Monica, CA. · Department of Radiation Oncology, University of California Helen Diller Comprehensive Cancer Center, San Francisco, CA. · Pubmed 25245425
2014
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, Arome, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, DE, USA. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · Advanced BC.org, New York, USA. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25244983
  • From the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco. · Pubmed 25006724
  • Joyce O'Shaughnessy, Baylor Charles A. Sammons Cancer Center, Texas Oncology · Joyce O'Shaughnessy, US Oncology, Dallas · Beth Hellerstedt Texas Oncology-Round Rock, Austin, TX · Lee Schwartzberg, Accelerated Community Oncology Research Network · Lee Schwartzberg, The West Clinic, Memphis · Denise A. Yardley, Sarah Cannon Research Institute · Denise A. Yardley, Tennessee Oncology, Nashville, TN · Michael A. Danso, US Oncology · Michael A. Danso, Virginia Oncology Associates, Norfolk · Nicholas Robert, Virginia Cancer Specialists, Fairfax · Paul Richards, Blue Ridge Cancer Care, Salem, VA · Kathy D. Miller, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN · Hope S. Rugo, University of California, San Francisco Comprehensive Cancer Center, San Francisco · Robert W. Carlson, Stanford Comprehensive Cancer Center, Palo Alto, CA · Richard S. Finn, Geffen School of Medicine at University of California, Los Angeles · Richard S. Finn, Translational Research in Oncology, Los Angeles, CA · Marcus Neubauer, Kansas City Cancer City, Overland Park, KS · Mansoor Saleh, Georgia Cancer Specialists, Sandy Springs, GA · Jennifer M. Specht, University of Washington, Seattle Cancer Care Alliance, Seattle, WA · Eric Charpentier, Ignacio Garcia-Ribas, Sanofi, Cambridge · and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 25349301
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Department of Breast Medical Oncology, Multidisciplinary Breast Cancer Research Program, University of Texas MD Anderson Cancer Center, Houston, USA. · Institut de Cancérologie de l'Ouest, René Gauducheau, Centre de Recherche en Cancérologie, Nantes Saint Herblain, France. · Department of Medicine, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo. · Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. · Breast Cancer Centers, Memorial Cancer Institute, Hollywood. · Breast Oncology and Clinical Trials Education, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Oncologic Centre, AZ Nikolaas, Sint-Niklaas, Belgium. · Sarah Cannon Research Institute, Nashville, USA. · Centre des Maladies du Sein Deschênes-Fabia, CHU-Hôpital du Saint Sacrement, Québec, Canada. · Multidisciplinary Breast Centre and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Ironwood Cancer & Research Centers, Chandler. · Novartis Pharmaceuticals Corporation, East Hanover. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 25231953
  • A. Jo Chien, Pamela N. Munster, Michelle E. Melisko, Hope S. Rugo, John W. Park, Andrei Goga, Glenna Auerback, Elham Khanafshar, and Mark M. Moasser, Helen Diller Family Comprehensive Cancer Center · A. Jo Chien, Pamela N. Munster, Michelle E. Melisko, Hope S. Rugo, John W. Park, Andrei Goga, Glenna Auerback, Elham Khanafshar, Karen Ordovas, and Mark M. Moasser, University of California San Francisco, San Francisco, CA · and Kevin M. Koch, GlaxoSmithKline, Research Triangle Park, NC. · Pubmed 24711549
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal · European School of Oncology, Milan, Italy European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, Denmark. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · AdvancedBC.org, New York. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25234545
  • Ines Vaz-Luis, Melissa E. Hughes, Harold J. Burstein, Jane C. Weeks, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute · Beverly Moy, Massachusetts General Hospital, Boston, MA · Ines Vaz-Luis, Instituto de Medicina Molecular, Lisbon, Portugal · Rebecca A. Ottesen and Rizvan Mamet, City of Hope, Duarte · Hope S. Rugo, University of California, San Francisco, San Francisco, CA · Stephen B. Edge, Roswell Park Cancer Institute, Buffalo, NY · Stephen B. Edge, Baptist Cancer Center, Memphis, TN · and Ana M. Gonzalez-Angulo and Richard L. Theriault, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 24888816
  • Sarah Cannon Research Institute/Tennessee Oncology, PLLC, 250 25th Avenue N, Ste 100 Nashville, TN 37203, USA. · Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, Los Angeles, CA 90033, USA. · University of Pittsburgh Cancer Institute, 200 Lothrop Street, Pittsburgh, PA 15213, USA. · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA 94115, USA. · Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, One Medical Center Dr, Lebanon, NH 03756, USA. · AdvancedBC.org 250 West 82 Street, #42, New York, NY 10024, USA. · Statistical Innovations Inc, 375 Concord Avenue, Belmont, MA 02478, USA. · Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA. · 1] EpiSource, LLC, 53 Fenwick Road, Waban, MA 02468, USA [2] Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118, USA. · Pubmed 24743708
  • University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, USA. · Pubmed 24615500
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA · Institut Multidisciplinaire D'Oncologie, Genolier, Switzerland. · Pubmed 25085504
2013
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143-0875, USA. · Pubmed 23649189
  • University of California San Francisco, San Francisco, California. · Pubmed 24892840
  • University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 24637554
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, Box 1710, San Francisco, CA, 94143-1710, USA, · Pubmed 24062208
2018
  • From the University of Texas M.D. Anderson Cancer Center, Houston (J.K.L.), and the Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas (J.L.B.) - both in Texas · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (H.S.R.), and Pfizer (R.G.W.Q., D.M., I.C.T., A.L.H.), San Francisco, University of California, Los Angeles, Los Angeles (S.A.H.), and Kaiser Permanente, Northern California, Vallejo (L.F.) - all in California · the Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technische Universität München (J.E.), and Interdisziplinäres Onkologisches Zentrum München (W.E.) - both in Munich, Germany · Institut Paoli-Calmettes, Marseille (A.G.), and Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulouse (H.R.) - both in France · Seoul National University Hospital (K.-H.L.) and Samsung Medical Center (Y.-H.I.) - both in Seoul, South Korea · Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel (R.Y.) · Banner M.D. Anderson Cancer Center, Gilbert, AZ (L.A.M.) · and Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Oncología, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid (M.M.). · Pubmed 30110579
2016
  • aDepartment of Medical Oncology, Dubai Hospital, UAE bUniversity of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. · Pubmed 27755140
  • From University of California, San Francisco (UCSF) (H.S.R., C.Y., L.J.V., M.B.B., N.M.H., A.J.C., C.E., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California San Diego, San Diego (A.M.W., R.S.), and University of Southern California, Los Angeles (D.T.) - all in California · University of Chicago (O.I.O., R.N.), and Loyola University (K.S.A.), Chicago · University of Pennsylvania, Philadelphia (A.D.) · Gemini Group, Ann Arbor, MI (J.P.) · University of Texas M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), UT Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas · University of Minnesota, Minneapolis (D.Y.), and Mayo Clinic, Rochester (J.C.B., T.C.H.) - both in Minnesota · Swedish Medical Center, Seattle (H.G.K.) · Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.) · University of Kansas, Lawrence (Q.J.K.) · University of Arizona, Tucson (J.E.L., R.K.V.), and Mayo Clinic, Scottsdale (D.W.N.) - both in Arizona · Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.) · University of Denver, Denver (A.D.E.) · Inova Fairfax Hospital, Falls Church, VA (K.K.E.) · and Emory University, Atlanta (W.C.W.). · Pubmed 27406347
2015
  • Department of Medicine, University of California, 1600 Divisadero St., Box 1710, San Francisco, CA, 94115, USA, · Pubmed 26208485
2014
2013
  • University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisidero Street, Box 1710, San Francisco, CA 94143-1710, USA. · Pubmed 23143215
  • Authors' Affiliations: Breast Cancer Medicine Service, Departments of Pathology, Biostatistics, and Radiology, Memorial Sloan-Kettering Cancer Center; Weill Medical College of Cornell University, New York; Dana-Farber Cancer Institute; Massachusetts General Hospital, Boston, Massachusetts; Mayo Clinic, Rochester, Minnesota; Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia; University of North Carolina at Chapel Hill, Chapel Hill; Duke University Medical Center, Durham, North Carolina; University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California; University of Alabama at Birmingham, Birmingham, Alabama; and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland. · Pubmed 23965901
  • Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA 94115, USA. · Pubmed 23135909
2012
  • University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, 2nd floor, San Francisco, CA 94115, USA. · Pubmed 23148612
Unspecified
2019
  • 1Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 USA. · 0000 0004 0386 9924 · grid.32224.35 · 2University of California San Francisco, 1600 Divisadero Street, San Francisco, CA 94115 USA. · 0000 0001 2297 6811 · grid.266102.1 · 3University of California San Francisco, 1600 Divisadero Street, San Francisco, CA 94115 USA. · Pubmed 31840050
  • 1Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA USA. · 0000 0001 2297 6811 · grid.266102.1 · 2Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA USA. · 3Department of Pathology, University of California San Francisco, San Francisco, CA USA. · Pubmed 31240240
2014
  • A. Jo Chien, Pamela N. Munster, Michelle E. Melisko, Hope S. Rugo, John W. Park, Andrei Goga, Glenna Auerback, Elham Khanafshar, and Mark M. Moasser, Helen Diller Family Comprehensive Cancer Center · A. Jo Chien, Pamela N. Munster, Michelle E. Melisko, Hope S. Rugo, John W. Park, Andrei Goga, Glenna Auerback, Elham Khanafshar, Karen Ordovas, and Mark M. Moasser, University of California San Francisco, San Francisco, CA · and Kevin M. Koch, GlaxoSmithKline, Research Triangle Park, NC. · Pubmed 24711549
2014
  • On behalf of Breast Cancer Expert Group of Indian Cooperative Oncology Network (ICON Trust), . · Pubmed 24947101
Miscellaneous institutions in San Francisco
2019
  • 1Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 USA. · 0000 0004 0386 9924 · grid.32224.35 · 2University of California San Francisco, 1600 Divisadero Street, San Francisco, CA 94115 USA. · 0000 0001 2297 6811 · grid.266102.1 · 3University of California San Francisco, 1600 Divisadero Street, San Francisco, CA 94115 USA. · Pubmed 31840050
Genentech Inc.
2018
  • From the Barts Cancer Institute, Queen Mary University of London, London (P.S.) · Perlmutter Cancer Center, New York University School of Medicine, New York (S.A.) · the Department of Medicine, University of California, San Francisco, San Francisco (H.S.R.), and Genentech, South San Francisco (L.M., S.Y.C., R.F.) - both in California · University Hospital Heidelberg, Heidelberg, Germany (A.S.) · Centro de Pesquisa em Oncologia, Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre (C.H.B.), and the University of São Paulo, São Paulo (R.H.) - both in Brazil · Aichi Cancer Center Hospital, Nagoya, Japan (H.I.) · the Department of Medical Oncology, Institut Curie, Paris (V.D.) · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.) · Florida Cancer Specialists and Research Institute, New Port Richey (G.S.W.) · Roche, Basel, Switzerland (V.H., A.H.) · Dana-Farber Cancer Institute, Boston (E.P.W.) · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S.L.) · and the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore (L.A.E.). · Pubmed 30345906
Washington University
2016
  • From the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of San Francisco School of Medicine, San Francisco, CA; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO. · Pubmed 27249746
University of San Francisco
2016
  • From the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of San Francisco School of Medicine, San Francisco, CA; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO. · Pubmed 27249746
37 Other Locations Show
Yearly article counts 023272321211918300
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.